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ABSTRACT 
 
 
Transcriptional Regulation and Chromatin Remodeling Mechanisms at PHO5 
(May 2004) 
Christopher Dumas Carvin, B.S., Louisiana State University 
Chair of Advisory Committee: Dr. Michael Kladde 
 
Regulation of gene expression is vital for proper growth and prevention of 
disease states. In eukaryotes this regulation occurs in the context of chromatin 
which creates an inherent barrier for the binding of trans-acting factors, such as 
transcription factors and RNA polymerase. This dissertation focuses on the role 
of transcriptional activators and chromatin remodeling coactivators in the 
regulation of the repressible acid phosphatase gene PHO5. Our studies show 
that histone methylation at lysine 4 of histone H3 is required for the full 
repression of PHO5 and GAL1-10. We show that bromodomains, a domain 
conserved in chromatin remodeling coactivators, may function to stabilize 
binding. Finally, we present a strategy using DNA methyltransferases as in vivo 
probes to detect DNA-protein interactions and examine chromatin structure. We 
extend this strategy to zinc-finger proteins which can be engineered to bind to 
any desired DNA sequence as a means of targeting methylation with potential 
use in epigenetic silencing. 
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CHAPTER I* 
INTRODUCTION 
 
SCOPE 
 The primary scope of this dissertation is to explore the role of chromatin 
remodeling enzymes in transcriptional regulation using the PHO5 gene from 
Saccharomyces cerevisiae as a model. I will present evidence for a role of 
histone methylation in transcriptional repression of PHO5 and GAL1-10. Next, 
the role of bromodomains in transcriptional activation will be further 
characterized. This dissertation will also demonstrate the use of targeted 
cytosine methylation to detect protein-DNA interactions, chromatin structure and 
to introduce de novo methylation to allow for epigenetic silencing in higher 
eukaryotes.  
The first part of the introduction provides background information in the 
field of chromatin structure with an emphasis on its repressive role in gene 
expression. The middle will detail the myriad of chromatin remodeling enzymes 
which are utilized to effect transcriptional activation and repression. The last 
part will introduce the yeast repressible acid phosphatase gene PHO5 as an ideal 
model system for the study of transcriptional regulation.  
 
                                                 
This dissertation follows the style and format of Cell. 
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SIGNIFICANCE 
 The packaging of DNA into chromatin creates an inherent repressive 
environment for the binding of trans-acting factors, such as transcription factors 
and the DNA replication machinery. Hence, eukaryotes have a variety of 
chromatin remodeling enzymes which remodel local chromatin structure to make 
it more accessible. These remodeling enzymes are highly conserved throughout 
all eukaryotic organisms and defects in these complexes have been correlated 
with a variety of diseases, including cancer. This dissertation will focus on the 
roles of histone methylation and bromodomains in gene expression. It will also 
introduce the use of DNA methyltransferases to characterize chromatin structure 
and detect protein-DNA interactions in vivo. 
 
CHROMATIN STRUCTURE 
 In order for DNA to fit into the nucleus of a cell it must be heavily 
compacted. If the DNA sequence that comprises the human genome was 
stretched out end to end, it would reach three meters in length. This must be 
compressed to fit inside a nucleus that is five micrometers in diameter; thus a 
greater than 10,000-fold compaction is needed. This packaging of DNA is 
referred to as chromatin structure and is a widely-studied process with 
connections to a myriad of biological processes and diseases. 
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 While chromatin is heavily studied, there is a lot that remains unknown. 
Most of what is known is at the first level of compaction. 146 bp of DNA is 
wrapped up by a histone octamer protein complex consisting of two copies each 
of histone H2A, H2B, H3, and H4 to form the nucleosome (Fig. 1-1), the basic 
repeating unit of chromosome organization (Richmond et al., 1988). An array of 
nucleosomes separated by small stretches of histone-free regions called linkers 
make up the “beads on a string” form and it is this form that most research 
focuses on. From here on, higher forms of chromatin organization occur. In 
mitotic condensation, a DNA molecule is packaged greater than 50,000 fold. 
 
 
Figure 1-1. Crystal structure of the nucleosome core particle. 
Ribbon diagram of the crystal structure at 2.5 Å resolution of 146 bp of DNA wrapped around 
histone octamer to form the nucleosome core particle (Harp et al., 2000). Random coils 
protruding from the nucleosome represent parts of the N-terminal tails of histones that yield 
high electron density in the crystal structure.  The bulk of the N-terminal tails are not visible.  
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 This heavy compaction creates a naturally repressive environment for 
almost all proteins including transcription factors, RNA polymerase, and the DNA 
replication/repair machinery. Chromatin is classified into two types based on the 
degree of compaction: euchromatin and heterochromatin. Euchromatin is less 
compacted than heterochromatin and is considered transcriptionally active 
chromatin while heterochromatin is generally silent. Some elegant studies using 
DNA methyltransferases as probes in vivo have shown that DNA packaged into a 
nucleosome is most inaccessible near the center or dyad. Within the first two 
helical turns of the nucleosome edge, there is modest accessibility but it is still 
significantly less than that seen in the linker region (Kladde and Simpson, 1994; 
Kladde et al., 1996).  
 A large percentage of trans-acting factor binding sites, such as TATA 
boxes and upstream activating sequences (UAS) are found in nucleosome-
containing regions. This may be a result of evolutionary pressure as a means of 
controlling gene expression or just simply due to the fact that most linker 
regions are very small and the vast majority of DNA is packaged into 
nucleosomes. The actual size of linker regions is variable in different eukaryotes, 
ranging from zero to 100 bp with the shortest linker lengths in lower eukaryotes 
and the longest in animals (Wolfe, 1993). In any case, local chromatin 
remodeling is required for these sites to be utilized. Eukaryotes have developed 
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a highly conserved series of protein complexes which function to remodel 
chromatin. 
 
CHROMATIN REMODELING 
 It is still unclear as to what precise mechanism(s) are involved in 
chromatin remodeling. In some instances, nucleosomes physically slide from one 
DNA region to another. A study showed that during activation of IFN-β, a single 
nucleosome is repositioned downstream by 36 bp, which exposes the TATA box 
(Lomvardas and Thanos, 2001). Further, the same authors showed that when 
the nucleosome is artificially positioned such that the TATA box is exposed prior 
to activation, IFN-β induces at a faster kinetic rate and obviates the need for 
certain chromatin remodeling enzymes (Lomvardas and Thanos, 2002). 
Additionally, recent evidence suggests that nucleosomes may be physically 
removed from DNA (Reinke and Hörz, 2003; Boeger et al., 2003), however, this 
is difficult to distinguish from a third potential mechanism where nucleosomes 
remain fixed but instead render the DNA accessible by conformational changes 
in the nucleosome structure.  
Chromatin remodeling is an active process and requires a myriad of 
highly conserved protein complexes. There are two general classes of chromatin 
remodeling enzymes. The first class is called ATP-dependent chromatin 
remodelers (reviewed in Becker and Hörz, 2002). These complexes are defined 
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by their use of ATP hydrolysis in nucleosome remodeling. The most widely 
studied complex is the Swi-Snf complex in yeast, named for its role in mating-
type switching as well as sucrose fermentation (reviewed in Martens and 
Winston, 2003). Defects in the human Swi-Snf complex are linked to a variety of 
disorders and diseases, including cancer. There are other related ATP-
remodeling chromatin complexes in yeast, including RSC, Ino80.com, and ISWI, 
which regulate a variety of biological processes. It is important to note that 
while ATP-dependent chromatin remodelers are typically thought to remodel 
chromatin to mediate transcriptional activation, they are involved in 
transcriptional repression as well (Martens and Winston, 2002).  
A second class of chromatin remodeling enzymes involves the post-
translational modification of histones. At present, histones have been shown to 
be modified by acetylation, methylation, phosphorylation, sumoylation and 
ubiquitination. These modifications mediate a complex signaling pathway to 
distinguish between active versus inactive chromatin that is referred to as the 
“histone code” (reviewed in Fischle et al., 2003). 
Of all the known modifications, histone acetylation is by far the most 
extensively studied. Acetylation of certain lysines in the N-terminal tails of 
histones H3 and H4 is associated with transcriptional activation. During 
transcriptional activation of most genes, increased acetylation is observed in the 
promoter region (reviewed in Kurdistani and Grunstein, 2003). Histone 
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acetylation mediates chromatin remodeling by two main mechanisms. First, the 
acetylation of lysine residues neutralizes the positive charge of the N-terminal 
tails and increases the alpha-helical content which may reduce the affinity of the 
tail for DNA and/or histone-histone interactions (reviewed in Hansen et al., 
1998). Additionally, histone acetylation may serve as a target for the 
recruitment of other transcriptional activators. This concept will be explored 
further in a later section (see bromodomains). 
Histone acetylation is catalyzed by a class of protein complexes called 
histone acetyltransferases (HATs). The first such HAT, HAT A, was discovered in 
the ciliated protozoan Tetrahymena thermophila (Brownell et al., 1996). HAT A 
is homologous to the Saccharomyces cerevisiae protein Gcn5 and is highly 
conserved in higher eukaryotes. Gcn5 is the catalytic subunit of SAGA and is 
required for its transcriptional activation and the ability to acetylate histones in 
vivo (Gregory et al., 1998; Kuo et al., 1998; Wang et al., 1998; Krebs et al., 
1999; Syntichaki et al., 2000). Conversely, there are histone deacetylase 
complexes (HDACs) which counteract HAT activity to silence gene expression 
(reviewed in Kurdistani and Grunstein, 2003). The regulation of HATs and 
HDACs is key to proper gene expression. 
Another emerging histone modification is histone methylation. Like 
histone acetylation, the methylation state plays a key role in determining active 
and inactive chromatin. However, whereas acetylation is correlated strictly with 
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active chromatin, methylation is utilized to demarcate euchromatin as well as 
heterochromatin. The difference lies not in whether the nucleosome is 
methylated, but rather in which residue is methylated (Noma et al., 2001). 
In higher eukaryotes, heterochromatic silencing is mediated by histone 
methylation at lysine 9 of histone H3 (Rea et al., 2000). Defects in the histone 
methyltransferase Suv39h responsible for K9 methylation impairs proper 
heterochromatin formation and increases genomic instability (Peters et al., 
2001). The heterochromatic coating protein HP1 selectively recognizes and 
binds to K9-methylated nucleosomes (Bannister et al., 2001; Lachner et al., 
2001). 
In contrast, euchromatin is marked by methylation at lysine 4 of histone 
H3. All K4 methylation in yeast is mediated by the COMPASS complex (Miller et 
al., 2001), with the catalytic subunit being the histone methyltransferase Set1 
(Briggs et al., 2001). A recent study looking at several genes demonstrated, that 
Set1-dependent methylation primarily occurs within the promoter and 5’ portion 
of coding regions (Ng et al., 2003b) and is required for full expression of several 
euchromatic genes (Nislow et al., 1997; Santos-Rosa et al., 2002).  
Recent publications have begun to elucidate the regulation of Set1 and its 
role in transcription. Set1-dependent methylation requires histone ubiquitination 
of histone H2B at lysine 123 via the Rad6-Bre1 complex. Rad6-deficient strains 
or strains in which lysine 123 of histone H2B has been mutated to arginine 
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contain no detectable K4 methylation (Sun and Allis, 2002). This is the first 
example where a modification on one histone is required for the modification on 
another. Histone modifications can also regulate other modifications on the 
same histone, e.g. histone phosphorylation at serine 10 leads to increased 
histone acetylation of lysine 14 of histone H3 (Lo et al., 2000). Interestingly, 
loss of histone ubiquitination leads to loss of histone methylation; however, Set1 
is still recruited (Ng et al., 2003b). 
The Paf1-Rtf1 complex is required for histone ubiquitination by Rad6-Bre1 
and hence it is required for K4 methylation as well. This complex is involved in 
transcriptional elongation and interacts with the phosphorylated C-terminal 
domain of RNA polymerase II (Krogan et al., 2003a; Ng et al., 2003b). As seen 
before, loss of Paf1 prevents histone ubiquitination but Rad6 is still recruited, 
however, no recruitment of the COMPASS complex is observed. The mechanism 
which prevents enzyme activity despite factor recruitment is not known. 
Based on these observations, a model has been proposed in which K9 
methylation is the signal for transcriptional repression while K4 methylation 
signals activation; however, other evidence suggests that the true mechanism is 
more complicated. Defects in Set1 cause loss of telomeric and rDNA silencing 
(Briggs et al., 2001; Bryk et al., 2002; Krogan et al., 2002a). Likewise, the 
Rad6-Bre1 and Paf1-Rtf1 complexes also have roles telomeric silencing (Sun and 
Allis, 2002; Krogan et al., 2003a; Ng et al., 2003a). It has been shown that 
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these complexes have a repressive role on genes found in active chromatin. 
Additionally, another histone methyltransferase, Set2, which is also involved in 
transcriptional elongation, appears to have positive and negative roles in 
transcription.  
Chapter II of this dissertation will explore the role of Set1 in the 
regulation of the yeast repressible acid phosphatase gene PHO5. I will present 
evidence that Set1 can also be a repressor of genes in active chromatin regions. 
 
TRANSCRIPTIONAL ACTIVATION BY RECRUITMENT 
 In order to properly control gene expression, the cell must overcome the 
repressive structure of chromatin using an array of chromatin remodelers as 
detailed previously. The extent of chromatin remodeling must be restricted to 
localized regions of the desired gene’s promoter to minimize effects on 
expression of neighboring genes. 
The most current model is referred to as the transcriptional activation by 
recruitment model (Fig 1-2). According to this model, site-specific DNA-binding 
transcription factors initially occupy their binding site(s) in DNA. These activators 
contain activation domains which can bind to and recruit both coactivators and 
the general transcription machinery (reviewed in Fry and Peterson, 2001). 
Recruitment of the chromatin remodeling coactivators perturbs chromatin 
structure which allows increased accessibility for general transcription factors 
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and RNA polymerase. Additionally, it has been demonstrated that chromatin 
remodeling enzymes can also interact with the general machinery, such as TBP 
(Sterner et al., 1999; Dudley et al., 1999; Bhaumik and Green, 2002). Thus, the 
primary activator and the recruited coactivators both directly assist in the 
recruitment of RNA polymerase. We and others have also shown that the 
primary activator binding is also dependent on the recruited coactivators 
(Dhasarathy, Carvin, Jessen and Kladde, manuscript in preparation; Duina and 
Winston, 2004). This may be a result of the protein-protein interactions of the 
activator with its coactivators which in turn may cooperatively stabilize the initial 
DNA-protein interaction. It may also be a result of chromatin remodeling which 
increases the accessibility of DNA.  
 
 
Figure 1-2. Transcriptional activation by recruitment. 
In this model the primary activator initially binds to its cognate DNA site. Upon binding, chromatin 
remodeling coactivators are recruited by the activator’s activation domain. These coactivators may stabilize 
primary activator binding, remodel chromatin structure, and help recruit RNA polymerase. Adapted with 
permission from Archana Dhasarathy. 
   
 
12
 
 
 
 An earlier study showed that yeast genes could be classified into three 
distinct classes based on their requirement for the chromatin remodelers Swi-
Snf and SAGA: 1) those genes which require both Swi-Snf and SAGA, 2) those in 
which either SWI-SNF or SAGA is required but not both, and 3) those which are 
independent of both Swi-Snf and SAGA (Biggar and Crabtree, 1999). The class 
where only one of the complexes is required suggests that, while these two 
complexes perform distinct functions, their overall activity is functionally 
redundant to one another. This is reinforced by the observation that 
overexpression of subunits in SAGA can compensate for Swi-Snf defects 
(Wallberg et al., 2000). One of the ongoing projects in the laboratory is 
currently investigating the differences between genes which are strictly 
dependent on chromatin remodelers versus those which are largely independent 
of individual chromatin remodelers. 
 
BROMODOMAINS 
 In the previous section, the interplay between coactivators in 
transcriptional activation was discussed. Some recent studies have begun to 
elucidate the temporal order of recruitment of factors during activation. An 
elegant study by Nasmyth and colleagues determined the temporal order of 
recruitment of chromatin remodelers at the cell cycle-regulated HO gene 
(Cosma et al., 1999). In this case, the ATP-dependent chromatin remodeler Swi-
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Snf was required for the stable association of the histone acetyltransferase 
SAGA and both complexes remained stably bound to the promoter after 
dissociation of the activator that recruited them, Swi5. However, at other genes 
such as α1 antitrypsin and IFN-β, the histone acetyltransferase precedes Swi-Snf 
recruitment (Agalioti et al., 2000; Soutoglou and Talianidis, 2002).  In vitro 
studies have shown that histone acetylation stabilizes the association of Swi-Snf 
to nucleosomal arrays (Hassan et al., 2001). 
 Several chromatin remodeling coactivator complexes, including Swi-Snf 
and SAGA, contain a highly conserved domain which was first discovered in the 
Drosophila protein brahma (Tamkun et al., 1992; Haynes et al., 1992) and 
hence named bromodomain(s) (reviewed in Jeanmougin et al., 1997). Further, 
the general transcription factor TAFII250 contains two bromodomains (Jacobson 
et al., 2000). It has been suggested that bromodomains function by recognizing 
acetyl-lysines in the N-terminal tails of histones (Dhalluin et al., 1999; Ornaghi 
et al., 1999; Hudson et al., 2000; Owen et al., 2000). The structure of the 
bromodomain has been solved and is shown in Figure 1-3. Thus, the presence 
of histone acetylation may lead to increased binding of factors necessary for 
transcription. 
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Figure 1-3. Structure of Gcn5 bromodomain complexed with acetylated H4 peptide. 
Crystal structure of Gcn5 bromodomain bound to histone H4 that is acetylated at lysine 16 
(Owen et al., 2000). Three conserved residues P371, M372, and Y413 which were shown to be 
important for its function (Syntichaki et al., 2000) are indicated. 
 
 A number of studies have tried to determine the extent to which 
bromodomains affect transcriptional activation. An in vitro study found that the 
bromodomains in Gcn5 of SAGA and Swi2 in Swi-Snf were essential for their 
stabile interaction with nucleosomal arrays, respectively (Hassan et al., 2002). 
In contrast, deletion of the bromodomain in the Spt7 subunit of SAGA had no 
effect on the binding of SAGA to nucleosomal arrays. Interestingly, fusion of the 
Spt7 bromodomain to Gcn5 could complement a deletion in the Gcn5 
bromodomain. The Gcn5 bromodomain was required for in vivo chromatin 
remodeling and Swi-Snf recruitment in an artificial reporter construct (Syntichaki 
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et al., 2000); however, it had no effect at the endogenous PHO5 gene which 
utilizes both Swi-Snf and SAGA for activation. 
It is difficult to determine the contribution of a bromodomain in binding in 
vivo since coactivators which do not bind DNA directly show only very modest 
enrichments in recruitment when analyzed by chromatin immunoprecipitation 
(ChIP). In Chapter III, we will present evidence that the fusion of the Gcn5 
bromodomain to the transcriptional activator Pho4 significantly enhances levels 
of PHO5 gene expression, consistent with the bromodomain increasing the 
binding affinity of Pho4 for the PHO5 promoter. 
   
PHO5 AS A MODEL SYSTEM 
 PHO5 is a stress response gene that is activated when the cell is starved 
for phosphate. It encodes the major acid phosphatase in yeast that is secreted 
to the periplasmic space to scavenge phosphate from phosphate esters that are 
present in the media. PHO5 is just one of 22 genes that are induced in 
phosphate-limiting media (Ogawa et al., 2000). PHO5 has been well 
characterized and serves as a primary model for the study of transcriptional 
activation and chromatin remodeling. 
 The pathway that regulates PHO-responsive genes has been determined 
(Fig. 1-4; reviewed in (Lenburg and O'Shea, 1996). Most PHO-responsive genes 
(21 of 22)  contain putative binding site(s) for the basic helix-loop-helix 
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transcription factor Pho4 (Ogawa et al., 2000). In high phosphate, the PHO 
cluster is repressed. This occurs by inactivation of Pho4 by phosphorylation by 
the cyclin/cyclin-dependent kinase Pho80-Pho85 (Kaffman et al., 1994). In 
phosphate-limiting conditions, the cyclin-dependent kinase inhibitor Pho81 
inactivates Pho80-Pho85 which allows for full activation of Pho4 (Schneider et 
al., 1994). Pho4 and Pho2 cooperatively bind to their cognate DNA sites to 
activate transcription (Barbaric et al., 1996; Barbaric et al., 1998). It is 
important to note that phosphate starvation also increases PHO81 expression 
through Pho4 binding (Yoshida et al., 1989b; Creasy et al., 1993), which 
provides a positive feedback loop during PHO activation. 
 
 
Figure 1-4. Regulatory pathway of PHO-responsive genes. 
The repressible acid phosphatases PHO5 and PHO8 are regulated by a signal transduction cascade. In 
repressed conditions these phosphatases are repressed by the inactivation of the primary activator Pho4 by 
the cyclin/cyclin-dependent kinase Pho80/Pho85. In activating conditions, Pho80/Pho85 is inhibited by the 
cyclin-dependent kinase inhibitor Pho81 which allows for full Pho4-dependent activation. Pho4 regulates 
Pho81 transcription which provides positive feedback on activation. 
   
 
17
 
 
 
 
 O’Shea and colleagues have determined that inactivation of Pho4 occurs 
through phosphorylation of five serine residues each which regulate a different 
inhibitory mechanism. Though Pho4 is constitutively expressed (Lemire et al., 
1985; Yoshida et al., 1989a), it is regulated by cellular localization (Fig. 1-5). In 
high phosphate, Pho4 is found almost exclusively in the cytoplasm (O'Neill et al., 
1996). Newly synthesized Pho4 enters the nucleus via the Pse1/Kap121 nuclear 
importer (Kaffman et al., 1998b). Pho80-Pho85 phosphorylates Pho4 at five 
different sites; two of those sites cause Pho4 to be exported from the nucleus 
by the nuclear receptor Msn5 (Kaffman et al., 1998a). A third phosphorylation 
site prevents re-entry into the nucleus. A fourth phosphorylation site controls 
the transcriptional activation potential of Pho4 by preventing its interaction with 
Pho2, which binds DNA cooperatively with Pho4 (Komeili and O'Shea, 1999). 
When shifted to no phosphate, Pho81 inhibits Pho80-Pho85 which allows Pho4 
to rapidly become almost fully nuclear within 1 hour (Komeili and O'Shea, 1999; 
Barbaric et al., 2001).  
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Figure 1-5. Phosphorylation of Pho4 regulates its nucleo-cytoplasmic localization. 
Pho80-Pho85 regulates Pho4 nuclear import by phosphorylation. Upon phosphoryation Pho4 is 
exported from the nucleus via the Msn5 nuclear exporter and its import via Pse1/Kap121 is 
inhibited. In activating conditions, Pho81 inactivates Pho80-Pho85 which allows for constitutive 
nuclear import of Pho4. 
 
 When a cell is starved for phosphate, it induces a number of 
phosphatases which try to salvage any environmental phosphate. The two main 
repressible phosphatases are the acid phosphatase Pho5 and the alkaline 
phosphatase Pho8. Pho5 is secreted to the periplasmic space, while Pho8 is 
localized to the vacuole. There are also two minor repressible acid phosphatases 
(rAPases) Pho10 and Pho11, which have little to no effect on overall rAPase 
activity (Neef and Kladde, unpublished observations). PHO5 expression requires 
Pho4 and Pho2, while at PHO8 only Pho4 is necessary (Münsterkötter et al., 
2000). While both genes are co-regulated, their expression levels are quite 
different. PHO5 is highly expressed; rAPase levels are induced greater than 200-
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fold in no phosphate versus high phosphate media (Neef and Kladde, 2003). 
PHO8 activation is approximately 10-times weaker than PHO5 (Münsterkötter et 
al., 2000). In addition, PHO5 only requires the chromatin remodelers SAGA and 
Swi-Snf during early times of induction or when the nuclear concentration of 
Pho4 is limiting (Dhasarathy, Carvin, Jessen and Kladde, manuscript in 
preparation; (Barbaric et al., 2001; Neef and Kladde, 2003). However, PHO8 
expression is strictly dependent on both Swi-Snf and SAGA (Gregory et al., 
1999). Thus, the PHO system provides an ideal system for investigations into 
the reasons for disparate requirements of chromatin remodeling coactivators. 
 The promoter structures of PHO5 and PHO8 have been well characterized 
(Almer et al., 1986; Barbaric et al., 1992). The PHO5 promoter contains five 
positioned nucleosomes and two upstream activating sequences where Pho4 
and Pho2 bind (Fig. 1-6). UASp1 is contained in a hypersensitive site which is 
accessible in high phosphate (Almer et al., 1986; Fascher et al., 1990; Carvin et 
al., 2003a; Carvin et al., 2003b). UASp2 and the TATA box are located in 
nucleosomes -2 and -1, respectively, and are inaccessible in repressed 
conditions. Thus, chromatin remodeling is required for full activation as well as 
for recruitment of the transcription machinery. Previous work had identified 
remodeling of four nucleosomes upon phosphate starvation; however work in 
our laboratory has shown that a fifth nucleosome is remodeled as well (Jessen, 
Dhasarathy, Carvin, McKinnie, and Kladde, manuscript in preparation).  
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Figure 1-6. The promoter structure of PHO5. 
The PHO5 promoter contains six positioned nucleosomes and two Pho4-Pho2 UAS sites. Note 
that UASp2 and the TATA box are located in the center of nucleosomes and hence block binding 
of trans-acting factors. Upon activation all five nucleosomes are remodeled. Tick marks indicate 
binding sites for the DNA methyltransferases M.CviPI and M.SssI.  
 
 Another advantage in studying PHO5 is that the Pho5 protein serves as 
its own reporter. Pho5 protein levels can be measured qualitatively by a plate 
assay using α-naphthyl-phosphate (Fig. 1-7); and quantitatively by a standard 
colorimetric phosphatase assay. PHO5 expression can be modulated by growing 
cells in different concentrations of inorganic phosphate (Fig. 1-8). Work in our 
laboratory has determined that varying phosphate concentration regulates the 
nuclear concentration of Pho4 and the amount of Pho4 bound at the PHO5 
promoter (Dhasarathy, Carvin, Jessen and Kladde, manuscript in preparation).  
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Figure 1-7. PHO5 expression requires the transcription factor Pho4. 
Plate assay detects Pho5 levels. In assay cells which express Pho5 protein are stained red. Cells 
lacking Pho4 (pho4) are white while cells which contain a constitutively active mutant of Pho4 
(O'Neill et al., 1996) leads to dark red color. 
 
 
 
Figure 1-8. PHO5 expression versus phosphate concentration. 
Repressible acid phosphatase assay of wild-type cells grown in varying concentrations of 
inorganic phosphate. High phosphate (13.4 mM) shows a very low amount of rAPase activity. 
Conversely, Pho5 is induced greater than 200-fold in no phosphate. Activities are reported in 
Miller units {(A420 x 1,000)/(OD600 x volume of cells assayed in mL x 10 min)}. 
 
 In conclusion, the PHO system is an ideal system for the study of 
transcriptional regulation and chromatin structure. In this dissertation, I present 
evidence that histone methylation plays a regulatory role in the repression of 
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PHO5. I provide a more detailed study on the ability of bromodomains to affect 
transcription factor binding. Our laboratory has developed the use of DNA 
methyltransferases which allow for the in vivo probing of chromatin structure 
(reviewed in Kladde et al., 1999). This dissertation has extended the use of DNA 
methyltransferases to allow for the detection of protein-DNA interactions, called 
targeted gene methylation (TAGM). Finally, I demonstrate that TAGM can be 
applied to target methylation via engineered zinc-finger proteins which can be 
altered to bind to any desired sequence.  These chimeric proteins can be used in 
the further study of the effects of DNA methylation and/or establish heritable 
transcriptional silencing. 
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CHAPTER II 
SET1 IS A NEGATIVE REGULATOR OF PHO5 AND GAL1-10 
 
OVERVIEW 
Post-translational modifications of histone amino-terminal tails are a key 
determinant in gene expression. In most eukaryotes, histone methylation plays 
a dual role in gene regulation. Methylation of lysine 9 of histone H3 associates 
with heterochromatin while methylation of lysine 4 correlates with active 
chromatin. K4 methylation via Set1, a component of the COMPASS complex, is 
regulated by the transcriptional elongation complex Paf1-Rtf1 and is required for 
expression of a subset of genes. This suggests that K4 methylation may play an 
activating role in transcription. However, we here show that K4 methylation 
negatively regulates gene expression as well. Strains that are deficient in Set1 
show enhanced expression of PHO5. Defects in the Paf1-Rtf1 complex show a 
greater derepression than that observed in defects in COMPASS. PHO84 and 
GAL1-10 are also derepressed in set1∆ cells. These results suggest that K4 
methylation, in conjunction with transcriptional elongation, may function in a 
negative feedback pathway for basal transcription of some genes while being a 
positive effector at others. 
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INTRODUCTION 
In eukaryotes, DNA is packaged with histone proteins to form 
nucleosomes which are further condensed into higher-order chromatin structure. 
This compaction serves as a barrier for the binding of factors important in 
cellular processes such as transcription and DNA replication. Thus, genes found 
in heavily condensed regions, such as heterochromatin, are typically 
transcriptionally silent. Expression of genes located in euchromatic regions, 
which are generally less compacted is also regulated by chromatin structure. 
Post-translational modifications of the amino-terminal tails of histone 
proteins are a key determinant in defining active (accessible) and repressed 
(inaccessible) chromatin. These modifications may alter chromatin structure 
directly by affecting histone-DNA and histone-histone interactions (reviewed in 
Hayes and Hansen, 2001). Further, they also allow for the recruitment of 
transcriptional activators or repressors. Acetylation of histone H3 at lysines 9 
and 14 is strongly correlated with transcriptionally active and accessible 
chromatin. Treatment of cells with histone deacetylase inhibitors, such as 
trichostatin A, leads to active chromatin states (Yang et al., 2000). 
Phosphorylation of serine 10 of histone H3 is also observed in transcriptional 
activation (Lo et al., 2000; Cheung et al., 2000) and has an unknown role in 
mitotic condensation (reviewed in Prigent and Dimitrov, 2003).  
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Histone methylation is correlated with both active and repressed 
chromatin states. In eukaryotes other than budding yeast, heterochromatic 
silencing is marked by methylation of histone H3 at lysine 9. Conversely, 
euchromatic regions are associated with histone methylation at lysines 4 and 79 
of histone H3 by the histone methyltransferases Set1 and Dot1, respectively 
(Noma et al., 2001). Set1 is the catalytic subunit of a large complex named 
COMPASS (Miller et al., 2001) and is responsible for all K4 methylation observed 
in yeast (Briggs et al., 2001). It is required for full activation of a subset of 
euchromatic genes, including RAM2, HAS1, INO1, PPH3, and MET16 (Nislow et 
al., 1997; Santos-Rosa et al., 2002). Paradoxically, defects in the Set1 or other 
components of COMPASS also lead to loss of rDNA (Briggs et al., 2001; Bryk et 
al., 2002) and telomeric (Krogan et al., 2002a) silencing.  
Set1-dependent methylation requires histone ubiquitination of lysine 123 
of histone H2B via the Rad6-Bre1 complex (Sun and Allis, 2002). Set1 is still 
recruited to promoter regions in RAD6 deletion strains; however no resulting K4 
methylation is observed (Ng et al., 2003b). This is the first evidence where a 
modification on one histone regulates the modification of another histone. 
Recent reports have also indicated that Set1 methylation is associated with 
transcriptional elongation (reviewed in Hampsey and Reinberg, 2003). The Paf1-
Rtf1 complex, which has been observed to be associated with RNA polymerase 
II, is required for K4 methylation as well as recruitment of the COMPASS 
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complex (Krogan et al., 2003a). Deletions in Paf1 lead to loss of histone 
ubiquitination by Rad6, however, Rad6 is still recruited (Wood et al., 2003). As 
seen with set1∆ mutants, strains lacking PAF1, RTF1 or RAD6 show loss of 
telomeric silencing (Sun and Allis, 2002; Krogan et al., 2003a; Ng et al., 2003a). 
In this report, we explore the role of Set1 in the transcriptional regulation 
of the phosphate-repressible PHO cluster. We find that loss of Set1 leads to 
increased levels of expression of the repressible acid phosphatase PHO5 in both 
repressed and active conditions. The expression of the high affinity phosphate 
transporter PHO84 is also higher in set1∆ than in wild-type strains. Deletions in 
critical components of the Rad6-Bre1 and Paf1-Rtf1 complexes, which are 
required for Set1-dependent methylation, also exhibit derepression of PHO5. 
Finally, we also observe derepression of the GAL1-10 locus. Our results suggest 
that histone methylation at K4 of histone H3 may be a repressive signal at some 
euchromatic genes while an activating one at others. 
 
MATERIALS AND METHODS 
Yeast strains  
The genotypes of the Saccharomyces cerevisiae strains used are listed in 
Table 2-1. The SET1 open reading frame was completely replaced in the diploid 
strain CCY694 (Neef and Kladde, 2003) with the kanMX4 selectable marker by a 
PCR-based method using the plasmid pRS400 as described (Brachmann et al., 
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1998). Gene replacement was confirmed by PCR and the resulting diploid was 
sporulated and tetrads were dissected to obtain wild-type (CCY1467 and 
CCY1468) and set1∆ haploids (CCY1471 and CCY1472). MBY1198 and MBY1217 
are gifts from Mary Bryk and are described elsewhere (Bryk et al., 2002). Yeast 
deletion strains were obtained from the homozygous deletion panel (Research 
Genetics).  
 
Growth conditions 
For PHO5 expression experiments, strains were pregrown in minimal 
media containing 0.7 g yeast nitrogen base with ammonium sulfate, phosphate, 
and amino acids (Bio 101), 2 g glutamine (Sigma), 20 g dextrose (Fisher), and 
3.9 g 2-N-morpholino ethanesulfonic acid (JT Baker), pH 5.5, per liter 
supplemented with 13.4 mM KH2PO4. Cells were then washed and resuspended 
in minimal media containing either 13.4 mM KH2PO4 or 13.4 mM KCl and 
incubated at 30oC with shaking for 6 h. PHO5 activity was measured by either 
repressible acid phosphatase activity assays or Northern hybridization as 
described (Neef and Kladde, 2003). Cells were also grown in rich YPD medium 
supplemented with 13.4 mM KH2PO4 (YPPD) overnight at 23oC without shaking. 
For GAL1-10 experiments, strains were pregrown overnight in YPD and then 
resuspended in YPD or YP galactose (YPG) + 0.5% glucose and incubated at 
30oC with shaking for 4 h. Northern hybridization probes were generated using 
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PCR amplification using the oligonucleotides listed in Table 2-2. mRNA levels 
were quantified by Storm 860 phosphorimager analysis. 
 
Table 2-1. Yeast strains. 
Strain Parent Genotype 
CCY1467 NA MATa leu2∆0 lys2∆0 ura3∆0 pho3∆::R 
CCY1471 NA MATa leu2∆0 lys2∆0 ura3∆0 pho3∆::R set1∆::kanMX4  
MBY1198 NA MATα his3∆200 ade2∆::hisG leu2∆0 ura3∆0 met15∆0 trp1∆63 
Ty1his3AI-236 Ty1ade2AI-515 cir0 
 
MBY1217 NA MATα his3∆200 ade2∆::hisG leu2∆0 ura3∆0 met15∆0 trp1∆63 
Ty1his3AI-236 Ty1ade2AI-515 cir0 set1∆::TRP1 
 
MBY1499 NA MATa ura3-52 lys2-801 ade2-101 trp1∆63 his3∆200 leu2∆1 hht1-
hhf1::LEU2 hht2-hhf2::HIS3 pRS414-HHT2-HHF2 
 
MBY1500 NA MATa ura3-52 lys2-801 ade2-101 trp1∆63 his3∆200 leu2∆1 hht1-
hhf1::LEU2 hht2-hhf2::HIS3 pRS414-hht2K4R-HHF2 
 
BY4743 NA MATa/MATα his3∆1/ his3∆1 leu2∆0/ leu2∆0 MET15/met15∆0 
LYS2/lys∆0 ura3∆0/ura3∆0 
 
CCY2895 
31570 
BY4743 
BY4743 
set1∆::kanMX4 
bre2∆::kanMX4 
32773 BY4743 lge1∆::kanMX4 
33771 BY4743 bre1∆::kanMX4 
34425 BY4743 rad6∆::kanMX4 
34611 BY4743 rtf1∆::kanMX4 
35727 BY4743 paf1∆::kanMX4 
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Table 2-2. Primers used for generation of Northern hybridization probes. 
Probe Sequence Primer name 
 
ACT1 GGCATCATACCTTCTACAAC DNO455 
ACT1 CGATGTTACCGTATAATTCC 
 
DNO456 
GAL1a CTCATTCAGAAGAAGTGATTGTAC CCO369 
GAL1 AGCACTGGCAAACCTTTC CCO370 
GAL10 CTCAGTTACAAAGTGAAAGTA CCO1135 
GAL10 GCTACTTGAGCCATATATGG CCO1136 
PHO5 TCTTTCCCTGGCGA DNO425 
PHO5a GTCATCCAAGTAGGTTGTGT DNO426 
PHO84 ATGAGTTCCGTCAATAAAGAT MKO928 
PHO84 TTATGCTTCATGTTGAAGTTG MKO929 
PPH3 ATGATGGACTTAGATAAGATTATAG CCO1138 
PPH3 TAAGAAATAGTCCATTTGAGATTT CCO1139 
aPrimer contains a 5' tail with core T7 promoter sequence. 
 
Chromatin immunoprecipitation (ChIP) assay  
To analyze histone H3 K4 methylation levels, antibodies specific for di- 
and tri-methylated forms of histone H3 K4 were used to immunoprecipitate 
chromatin from MBY1198 and MBY1217 strains grown in YPD. Quantitative PCR 
amplification was performed using primers ADO236 and LFO740 as described 
(Carvin et al., 2003a). 
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Figure 2-1. Loss of Set1 leads to higher levels of PHO5 in repressed and activated conditions.  
(A) Total repressible acid phosphatase (rAPase) activities from the CCY1467 wild-type strain and 
the CCY1471 set1∆ mutant strain grown in minimal high phosphate media for 6 h. Activities are 
reported as Miller Units as described previously (Neef and Kladde, 2003). Results are 
representative of five independent experiments. Similar results are observed using two 
independent wild-type and mutant segregants.  
(B) Northern analysis of RNA internally isolated in (A) for PHO5 and ACT1 mRNA levels. For 
quantification (fold relative to WT), PHO5 transcript levels in each lane are normalized to ACT1 
mRNA levels.  
(C) Total rAPase activities of strains grown in minimal no phosphate media for 6 hours. 
(D) Northern analysis of RNA internally isolated from cells in (C). 
 
RESULTS AND DISCUSSION 
Deletion of Set1 leads to increased levels of Pho5 
To determine the role that histone H3 K4 methylation has on PHO5 gene, 
we analyzed PHO5 expression levels in wild-type and set1∆ strains under both 
repressed and activating conditions. In order to distinguish repressible acid 
phosphatase levels as well as potential cross-hybridization in Northern analysis 
from that of the constitutive acid phosphatase Pho3, we used strains in which 
   
 
31
 
 
 
the entire coding sequence of PHO3 was deleted. In repressed conditions of 
minimal media supplemented with phosphate, set1∆ strains show significantly 
higher levels of rAPase activity than wild-type cells (Fig. 2-1A). This increased 
rAPase activity correlates with higher PHO5 mRNA levels in set1∆ cells, 
suggesting that this derepression is due to increased transcription (Fig. 2-1B). 
We also observed enhanced PHO5 expression in fully activating conditions of 
minimal media lacking phosphate (Fig. 2-1C). Although the fold-increase is 
lower, the increase by nearly 1000 Miller Units is substantial. Similarly, under no 
phosphate conditions, a modest but reproducible increase in PHO5 transcript 
was observed (Fig. 2-1D). To better quantify the level of derepression due to 
the deletion of SET1, we grew cells under conditions of higher basal expression, 
in rich medium supplemented with phosphate at 23oC.  Under these conditions 
rAPase activity is approximately 10-fold higher than when grown in minimal 
media containing phosphate at 30oC (compare levels observed for wild-type in 
Fig. 2-1A to that observed in Fig. 2-2A). PHO5 is still further enhanced in cells 
lacking Set1 (Fig. 2-2A-B). PHO5 expression is noticeably higher throughout a 
time course of phosphate starvation and is repressed slower in a set1∆ strain 
(data not shown). Additionally, yeast in which lysine 4 is mutated to arginine 
and hence cannot be methylated, show increased basal expression of PHO5 
(Fig. 2-2C). The lower fold derepression observed in this H3 K4R strain is likely 
due to the high basal expression that results from expression of the histone on a 
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plasmid. Nevertheless, K4 methylation contributes to the regulation of PHO5 and 
suggests that Set1 plays a role in the repression of the euchromatic gene PHO5. 
 
 
 
Figure 2-2. Derepression of PHO5 is observed in set1∆ cells when grown in YPPD. 
(A) Total rAPase activities from two independent wild-type and set1∆ strains grown in YPPD at 
23oC. rAPase activity results are representative of three independent experiments. 
(B) Northern analysis of RNA internally isolated from cells in (A). For quantification (fold relative 
to WT), PHO5 transcript levels in each lane are normalized to ACT1 mRNA levels. 
(C) rAPase activities of MBY1499 wild-type and MBY1500 histone H3 K4R mutant strains. 
 
 
Methylation of K4 of histone H3 is present at the PHO5 promoter  
In order to see if Set1 is regulating PHO5 directly, we investigated the 
methylation state of histone H3 at the PHO5 promoter. Chromatin 
immunoprecipitation (ChIP) was performed using antibodies specific for di- and 
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tri-methylated lysine 4 of histone H3 (Santos-Rosa et al., 2002). When cells are 
grown in YPD, which is limiting for inorganic phosphate and hence leads to 
significant PHO5 expression (Neef and Kladde, 2003), considerable amounts of 
both di- and tri-methylated forms of K4 are present at the PHO5 promoter (Fig. 
2-3). This enrichment is abolished in a strain that lacks Set1. This is consistent 
with results reported previously (Reinke and Hörz, 2003) and suggests that Set1 
is directly associated with PHO5.  
 
 
Figure 2-3. Set1-dependent K4 methylation is enriched at the PHO5 promoter. 
Chromatin immunoprecipitation analysis of wild-type MBY1198 and set1∆ MBY1217 strains 
grown in YPD media using antibodies specific for di- and tri- methylated forms of histone H3 K4. 
PCR amplifications of input and immunoprecipitated DNA samples using primers specific for the 
PHO5 promoter region are shown.  
 
 
Upstream regulators of Set1 also regulate PHO5  
 Histone ubiquitination of histone H2B at lysine 123 by the Rad6-Bre1 
complex is required for Set1 to methylate histone H3 K4. Additionally, recent 
reports have linked Set1-dependent methylation to transcriptional elongation via 
the Paf1-Rtf1 complex. Defects in Paf1 or Rtf1 lead to loss of K4 methylation. 
Since these complexes are necessary for K4 methylation, we surmised that 
defects in these complexes should have a similar phenotype to that observed in 
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set1∆. Deletions of both RTF1 and PAF1 cause significant increased expression 
of PHO5 with paf1∆ having a larger effect than rtf1∆ (Fig. 2-4A). This is 
consistent with previous results that have shown that a paf1∆ strain has a larger 
transcriptional effect than rtf1∆ (Squazzo et al., 2002). Further, PAF1 null strains 
reduce the association of Set1 with coding regions more than does a deletion of 
RTF1 (Ng et al., 2003b). Deletions in RAD6, BRE1 or LGE1, encoding 
components of the Rad6-Bre1 complex (Hwang et al., 2003), lead to increased 
PHO5 levels (Fig. 2-4B). Finally, deletions of SET1 or BRE2 of the COMPASS 
complex (Miller et al., 2001) also show enhanced rAPase expression (Fig. 2-4C).  
It is interesting to note that the Paf1-Rtf1 complex, which is genetically 
upstream of the Rad6-Bre1 and COMPASS complexes, has the largest effect on 
derepression. This suggests that Paf1-Rtf1 may recruit other components that 
regulate PHO5 expression. 
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Figure 2-4. Upstream regulators of Set1 also regulate PHO5 expression. 
(A) rAPase activities of wild-type, paf1∆, and rtf1∆ strains grown in minimal high phosphate 
media. The means ± 1 standard deviation from three independent experiments are shown.  
(B) rAPase activities of wild-type, bre1∆, lge1∆, and rad6∆ strains. 
(C) rAPase activities of wild-type, bre2∆, and set1∆ strains. The means ± 1 standard deviation 
from three independent experiments are shown.  
 
Set1 is a negative regulator of PHO84 expression  
 To test if other genes of the PHO cluster are regulated by Set1, we 
examined the expression of PHO84, which codes for the high affinity phosphate 
transporter. Like PHO5, PHO84 is only minimally expressed in high phosphate 
conditions and is highly expressed in media where phosphate is limiting. PHO84 
mRNA levels were studied in wild-type and set1∆ cells grown in YPPD. As seen 
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previously for PHO5, the strain lacking Set1 shows higher expression of PHO84 
than wild-type (Fig. 2-5A). Conversely, a reduction in the mRNA levels of the 
constitutive protein phosphatase PPH3 is observed in set1∆ (Fig. 2-5B) as has 
been shown previously (Santos-Rosa et al., 2002). The PHO84 results confirm 
the above-mentioned PHO5 results and demonstrates that Set1 is a repressor of 
other PHO genes while is required for full expression at others. 
 
 
Figure 2-5. Set1 regulates other PHO-responsive genes. 
(A) Northern analysis of PHO84 expression of wild-type and set1∆ strains grown in YPPD. For 
quantification (fold relative to WT), PHO84 transcript levels in each lane are normalized to ACT1 
mRNA levels. 
(B) Northern analysis of PPH3 expression in minimal media normalized to 18S RNA. 
 
GAL1-10 is also negatively regulated by Set1 
To determine if Set1 is involved in the repression of other genes not 
under phosphate control, we examined the GAL1-10 locus. Wild-type and set1∆ 
strains were grown in repressed conditions, YPD, and semi-activating conditions 
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YPG + 0.5% glucose and GAL1 and GAL10 mRNA expression was measured. No 
detectable GAL1 or GAL10 transcript was observed in YPD; however, both GAL1 
and GAL10 are expressed more in a set1∆ strain in YPG + 0.5% glucose (Fig. 2-
6). These data are consistent with two previous microarray analyses which also 
indicated that GAL1 has increased mRNA levels in a set1∆ deletion strain 
(Bernstein et al., 2002; Boa et al., 2003). A recent study has also shown that 
GAL10 is expressed significantly higher in a rad6∆ null as well as in set1∆ at 
early times of induction (Daniel et al., 2004). Thus, Set1 may negatively 
regulate a myriad of genes with different functions and regulatory mechanisms.  
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Figure 2-6. Set1 represses GAL1-10 expression. 
(A) Northern analysis of GAL1 expression of wild-type and set1∆ strains grown in YPD or YPG + 
0.5% glucose. For quantification (fold relative to WT), GAL1 transcript levels in each lane are 
normalized to ACT1 mRNA levels. 
(B) Northern analysis of GAL10 mRNA levels. For quantification (fold relative to WT), GAL10 
transcript levels in each lane are normalized to ACT1 mRNA levels. 
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CHAPTER III 
THE ROLE OF BROMODOMAINS IN TRANSCRIPTIONAL ACTIVATION 
 
OVERVIEW 
Post-translational modifications of histones are key regulatory events in 
transcription coordination. During transcriptional activation, the primary 
activator recruits a variety of coactivators which function to remodel chromatin 
as well as to recruit the transcriptional machinery. Histone acetylation is a 
determinant of transcriptionally active chromatin regions; however, its functional 
role has not been clearly defined. A number of chromatin remodeling 
coactivators contain a highly conserved bromodomain which selectively 
recognizes acetylated histones. Since chromatin remodeling coactivators do not 
bind DNA directly, it is difficult to quantify the promoter association accurately, 
and it is even harder to determine the individual contributions of each subunit in 
promoter interaction. In order to determine the function that the bromodomain 
motif may contribute in transcriptional activation, we fused the Gcn5 
bromodomain up to the transcriptional activator Pho4. This fusion leads to 
significant enhancement of PHO5 expression. Mutations in essential residues of 
the bromodomain alleviate this effect. We can use this strategy to measure 
accurately the effect of individual bromodomains on promoter binding and 
transcriptional activation. 
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INTRODUCTION 
 In eukaryotes, the process of transcription requires the interplay of DNA-
binding transcriptional activators, chromatin remodeling coactivators, and RNA 
polymerase. The primary activator is able to independently recruit all of these 
activities (reviewed in Fry and Peterson, 2001). At the yeast HO gene, the 
primary activator Swi5 recruits Swi-Snf and SAGA in a temporal manner and 
Swi-Snf and SAGA remain associated with the promoter after Swi5 has 
dissociated. An in vitro system using nucleosomal arrays has shown that histone 
acetylation stabilizes the binding of Swi-Snf (Hassan et al., 2001). This suggests 
a connection between the activity of one chromatin remodeling enzyme and the 
recruitment of another. 
 A number of chromatin remodeling complexes in yeast contain subunits 
which contain a highly conserved bromodomain which has been shown to be an 
acetyl-lysine binding domain (Dhalluin et al., 1999). Since histone acetylation 
usually increases at promoters during activation, the bromodomain may provide 
a functional link in the recruitment and stabilization of transcriptional 
coactivators. However, it is difficult to determine the relative contributions 
particular domains may have in binding using chromatin immunoprecipitation, 
since coactivators often cross-link poorly as they do not bind DNA directly. 
 Here, we show that fusion of the bromodomain from the Gcn5 histone 
acetyltransferase to the transcriptional activator Pho4 significantly increases the 
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ability of Pho4 to activate transcription. We observe a greater than eight-fold 
enhancement of PHO5 expression in repressed conditions. This effect is not 
seen when critical residues that make up the acetyl-lysine binding pocket of the 
bromodomain are mutated. This strategy provides a convenient way to test the 
effect that individual bromodomains may have on the binding affinity of 
coactivators to promoter regions. 
 
MATERIALS AND METHODS 
Yeast strains, plasmid construction, and growth conditions 
All strains used in this study are derived from CCY880 (MATa leu2∆0 
lys2∆0 ura3∆0 pho3∆::R). All bromodomain fusions were constructed by tagging 
Pho4 with 3xHA-(his)6-GPGS(G)6(SGG)2GLGST (linker)-BD fusion at its C-
terminus with the selectable marker URA3 immediately downstream. All 
constructs were integrated at the endogenous PHO4 locus so that the chimeric 
proteins would be expressed by the endogenous PHO4 promoter (Legrain et al., 
1986). Proper integration was screened by PCR. URA3, which was flanked by 
Zygosaccharomyces rouxii recombinase sites, was then recovered by 
homologous recombination (Roca et al., 1992). Bromodomain mutants were 
created by site-directed mutagenesis using the mutagenic primers described in 
(Syntichaki et al., 2000). All plasmids were sequence-verified prior to 
integration. 
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 Strains were pre-grown in minimal media containing 0.7 g yeast nitrogen 
base with ammonium sulfate, phosphate, and amino acids (Bio 101), 2 g 
glutamine (Sigma), 20 g dextrose (Fisher), and 3.9 g 2-N-morpholino 
ethanesulfonic acid (JT Baker), pH 5.5, per liter supplemented with 13.4 mM 
KH2PO4. Cells were reseeded to OD600 = 0.2 in minimal media containing either 
13.4 mM KH2PO4 or 13.4 mM KCl and incubated at 30oC with shaking for 6 h. 
PHO5 activity was measured by repressible acid phosphatase activity assays 
(Neef and Kladde, 2003). 
 
RESULTS AND DISCUSSION 
Fusion of the Gcn5 bromodomain to Pho4 enhances PHO5 expression 
in repressed conditions 
 To test whether the bromodomain of Gcn5 may affect the ability of Pho4 
to activate transcription, we fused it in-frame to C-terminus of Pho4 (Pho4-
Gcn5BD). The fusion was integrated at the endogenous Pho4 locus and its 
expression was regulated by the PHO4 promoter. We analyzed PHO5 expression 
levels by acid phosphatase assays as described previously (Neef and Kladde, 
2003). The Pho4-Gcn5BD fusion showed a dramatic increase in the expression 
of the repressible acid phosphatase gene PHO5 in repressed conditions (Fig. 3-
1). Though Pho4 is mainly localized to the cytoplasm in high phosphate, some 
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transient Pho4 binding is observed (Carvin et al., 2003a) and the addition of the 
bromodomain makes Pho4 a more potent activator.  
 
 
Figure 3-1. Fusion of the Gcn5 bromodomain to Pho4 increases PHO5 expression in high 
phosphate medium. 
rAPase activity assays of wild-type (Pho4) and bromodomain fusion (Pho4-Gcn5BD) strains 
grown in high phosphate media. The means ± 1 standard deviation from seven independent 
Pho4-Gcn5BD strains are shown. 
 
 
 Under fully activating conditions, no significant enhancement of 
expression is observed in the Pho4-Gcn5BD fusion strain (Fig. 3-2). Previous 
work has shown that histone acetylation levels are lower in phosphate-limiting 
media which has been attributed to complete nucleosome displacement (Reinke 
and Hörz, 2003; Boeger et al., 2003). The loss of acetylated histones would 
prevent the bromodomain from providing an additional binding contact. 
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Alternatively, Pho4 binding at the PHO5 promoter or PHO5 expression may have 
achieved saturated. 
 
 
 
 
Figure 3-2. Pho4-Gcn5BD does not show increased expression in the absence of phosphate. 
rAPase activity assays of wild-type (Pho4) and bromodomain fusion (Pho4-Gcn5BD) strains 
grown in no phosphate media. The means ± 1 standard deviation from seven independent 
Pho4-Gcn5BD strains are shown. 
 
Bromodomain mutants cannot increase PHO5 expression 
 It is formally possible that the enhanced expression seen is a result of 
higher Pho4 concentrations in the nucleus, however, previous work has shown 
that deletion of MSN5,  which leads to constitutive Pho4 nuclear localization, 
does not lead to higher PHO5 expression (Kaffman et al., 1998a). Additionally, 
we have that other Pho4 C-terminal fusions do not lead to derepression (Carvin 
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et al., 2003a). It is also possible that the bromodomain, which contains a 
number of acidic residues, contains a cryptic activation domain. To demonstrate 
that the additional induction seen in the Pho4-Gcn5BD fusion is a true result of 
the bromodomain, we mutated the bromodomain at two essential residues 
which were shown to be required for its function (Syntichaki et al., 2000). The 
P371T and M372A mutations completely abolish the enhanced expression 
observed (Fig. 3-3). This demonstrates that the bromodomain itself and it is not 
merely the result of a fusion protein which leads to the enhanced expression.  
 
 
Figure 3-3. Mutations in the Gcn5 bromodomain impair its function. 
rAPase activity assays of wild-type (Pho4), bromodomain fusion (Pho4-Gcn5BD), and mutated 
bromodomain fusion (Pho4-Gcn5BD P371T/M372A strains grown in high phosphate media. 
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CHAPTER IV 
TARGETED CYTOSINE METHYLATION FOR IN VIVO DETECTION OF PROTEIN-
DNA INTERACTIONS† 
 
OVERVIEW 
We report a technique, named targeted gene methylation (TAGM), for 
identifying in vivo protein binding sites in chromatin. M.CviPI, a cytosine-5 DNA 
methyltransferase recognizing GC sites, is fused to a DNA-binding factor 
enabling simultaneous detection of targeted methylation, factor footprints, and 
chromatin structural changes by bisulfite genomic sequencing. Using TAGM with 
the yeast transactivator Pho4, methylation enrichments of up to 34-fold occur 
proximal to native Pho4 binding sites. Additionally, significant, selective 
targeting of methylation is observed several hundred nucleotides away, 
suggesting the detection of long-range interactions due to higher-order 
chromatin structure. In contrast, at an extragenic locus lacking Pho4 binding 
sites, methylation levels are at the detection limit at early times following Pho4 
transactivation. Notably, substantial amounts of methylation are targeted by 
Pho4-M.CviPI under repressive conditions when most of the transactivator is 
excluded from the nucleus. Thus, TAGM enables rapid detection of DNA-protein 
                                                 
† The work presented in this Chapter has been published in the following paper: Carvin, C.D., 
Dhasarathy, A., Friesenhan, L.B., Jessen, W.J., and Kladde M.P. (2003). Targeted cytosine 
methylation for in vivo detection of protein-DNA interactions. Proc. Natl. Acad. Sci. USA 100, 
7743-7748 by permission of National Academy of Sciences, Copyright 2003. 
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interactions even at low occupancies and has potential for identifying factor 
targets at the genome-wide level. Extension of TAGM from yeast to vertebrates, 
which use methylation to initiate and propagate repressed chromatin, could also 
provide a valuable strategy for heritable inactivation of gene expression. 
 
INTRODUCTION 
The interaction of proteins with chromosomal target sites, either directly or 
through recruitment by DNA-bound factors, is central to many processes, 
including transcriptional activation and repression, replication and repair of DNA, 
recombination, and chromosome segregation. Therefore, strategies are needed 
that can efficiently identify specific chromosomal sites at which factors act. Few 
techniques are capable of demonstrating these interactions in the context of 
native chromatin in living cells, and these methods have limitations (Simpson, 
1999). For example, with footprinting techniques, protection against chemical 
(e.g., dimethyl sulfate) or enzymatic probes expressed in cells, e.g., DNA 
methyltransferases (DMTases) (Gottschling, 1992; Singh and Klar, 1992; Kladde 
and Simpson, 1994; Kladde et al., 1996; Xu et al., 1998b) or DNase I (Wang 
and Simpson, 2001), requires close proximity of the interacting factor to DNA 
sites that are modified or cleaved by the footprinting agent. Footprinting 
methods also require that the factor resists displacement by the enzymatic or 
chemical probe. Moreover, as many proteins can exclude probe access, a 
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footprint does not provide an unequivocal identity of the bound protein (Rigaud 
et al., 1991). To circumvent this latter problem, proteins have been fused to an 
endonuclease (Lee et al., 1998), however, the resulting DNA damage alters 
chromatin structure and activates checkpoint controls. Another method, 
chromatin immunoprecipitation (ChIP), employs in situ fixation with 
formaldehyde followed by immunoselection of DNA-bound complexes. The 
requirements for large numbers of cells and highly specific antibodies as well as 
low fixation efficiencies (ca. 0.1-0.5%) (Tanaka et al., 1999; Reid et al., 2000) 
present distinct disadvantages of ChIP analysis. The approach of tethering 
chromatin proteins to the Dam DMTase, which methylates GATC sites near their 
sites of chromosomal association, overcomes the above problems (van Steensel 
and Henikoff, 2000). This method has been used to detect factors bound at 
chromosomal regions containing multiple factor binding sites, e.g., 14 Gal4 (van 
Steensel and Henikoff, 2000) and 112 TetR sites (Lebrun et al., 2003); however, 
it is not known if it can detect a factor bound at a single binding site. In 
addition, sensitive quantification of methylation frequencies can only be 
performed for one dam site at a time and requires real-time PCR analysis. 
We report the specific targeting of cytosine methylation to promoters in 
living eukaryotic cells. Our strategy (Fig. 4-1), named TAGM, capitalizes on 
fusing chromatin-associating factors to M.CviPI, a cytosine-5 DNA 
methyltransferase (C5 DMTase) that methylates the C of a 2-bp GC site. This 
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short specificity provides a M.CviPI recognition site, on average, once every 27 
bp, increasing the frequency of DMTase sites at least 10-fold over DMTases that 
recognize 4-bp sites. Bisulfite genomic sequencing is used to provide a positive 
display of 5-methylcytosine (m5C) levels at many GC sites on a standard 
sequencing gel. We find that fusion of M.CviPI to a DNA-binding factor leads to 
substantial increases in, or targeting of, m5C proximal to factor binding sites that 
are accessible in chromatin. Moreover, m5C is selectively targeted distal to the 
site of the bound factor, suggesting detection of higher-order chromatin 
structure. Thus, TAGM is sensitive, requiring small numbers of cells to monitor 
the interaction of a factor with a single, native binding site. Since DNA 
methylation is a primary signal for establishing and maintaining repressive 
chromatin structures in vertebrates (Bird, 2002), our demonstration of targeting 
m5C in a eukaryote is a critical step toward achieving heritable, methylation-
dependent gene silencing in such organisms. 
 
 
Figure 4-1. The TAGM strategy for identifying DNA–protein interactions in vivo. 
Hypothetical sites protected against methylation (arrowheads) or directly methylated (asterisks) 
are indicated. 
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MATERIALS AND METHODS 
Yeast strains, plasmid construction, and growth conditions 
All yeast strains used in TAGM analyses have the S288C background and 
were derived from YPH500∆L (MATα ade2-101 ura3-52 his3-∆200 leu2-∆1 trp1-
∆63 lys2-∆1)(Kladde et al., 1996). Mutated Zif268 (mut Zif), which contains a 
single amino acid mutation (H58E) (Nardelli et al., 1991) that abolishes DNA 
binding, was cloned as an in-frame fusion to M.CviPI into pMPK1 under the 
control of the GAL1 promoter and integrated at LYS2 as previously described 
(Kladde et al., 1996). M.CviPI and mut Zif are separated by a linker peptide, 
GS(G)4SG4SG3LGST (Xu and Bestor, 1997). Pho4-M.CviPI was constructed by 
tagging Pho4 with 3HA-(his)6-GPGS(G)6(SGG)2GLGST (linker)-M.CviPI at its C-
terminus under control of the constitutively-expressed, endogenous PHO4 
promoter (Legrain et al., 1986). URA3, which was flanked by 
Zygosaccharomyces rouxii recombinase sites, was then deleted by homologous 
recombination (Roca et al., 1992).  
  For ChIP analysis, strains LFY2152 (S288C; MATα leu2-∆0 lys2-∆0 ura3-
∆0 pho3∆) with the endogenous PHO4 locus tagged at its N-terminus with a 
triple myc epitope or ADY2398 with wild-type PHO4 (no tag control), were used. 
Both strains also contain a mutated copy of the PHO5 promoter (deletion of 
both UASs, from −401 to −352 and −258 to −209) integrated at the extragenic 
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CAN1 locus.  
Strains were pre-grown in minimal media (2% raffinose, 20 mM 2-N-
morpholino ethanesulfonic acid [MES], pH 5.5, 14 mM L-glutamine, and 0.7 g 
yeast nitrogen base [YNB] without (NH4)2SO4, phosphate, or amino acids 
[Bio101]) that was brought to 13.4 mM KH2PO4. Cells were then washed and 
resuspended to an OD600 of 0.2 with the same minimal media containing either 
13.4 mM KH2PO4 (+Pi, repressive conditions) or 13.4 mM KCl (−Pi, activating 
conditions) that also contained 2% galactose. 
 
Bisulfite genomic sequencing  
Genomic DNA was rapidly isolated and analyzed by bisulfite genomic 
sequencing (Frommer et al., 1992; Clark et al., 1994) as modified (Kladde et al., 
1996). PCR products amplified from bisulfite-deaminated DNA using Jumpstart 
Taq DNA polymerase (Sigma) were purified and subjected to primer extension 
as described previously (Kladde et al., 1996), except that the final 
concentrations of dNTPs (A, C, T) and ddGTP were 50 µM and 150 µM, 
respectively. Exclusion of dGTP from the PCR product primer extension reactions 
yields high termination efficiencies (>96%)(Kladde et al., 1996) at template 
cytidines (m5C residues in vivo). Absolute frequencies of site methylation are 
calculated by dividing the intensity of a given band by all summed product 
intensities, including the run-off product at the top of the gel generated by 
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extension on non-methylated templates. Oligonucleotides used for the bisulfite 
genomic sequencing analysis of m5C levels are listed in Table 4-1. 
Table 4-1. Bisulfite genomic sequencing primers. 
Primer name Sequence Figure 
Oligonucleotides for PCR amplification. 
CAR1b1-60 CCATTTaAaaaACTCaaaACAATaTaaaAC 4-2D 
CAR1b2-61 TAtGGAATTAGAGtttTtAATGGAtGAG 4-2D 
PHO5a1-22 CCAAATaaaTATATaCCTTaCCAAaTAAaaTaACC 4-3 
PHO5a2-21 TAtAtATtGGAtTGATAAGTTAtTAtTGtAtATTGG 4-3 
PHO5b1-922 TTCAATTaCTAAATACAATaTTCCTTaaT 4-2, 4-4 
PHO5b2-924 GAAAAtAGGGAttAGAATtATAAATTTAGTtT 4-2, 4-4 
PHO8b1-246 ATAACCaCACCTaCAATaACaaTA 4-5A 
PHO8b2-247 TtGAGTtAGATttAGGAAtAAGAtGT 4-5A 
PHO84a1-918 ATaTTACCACCTTCaaTAAaaTaTTCTTTATaAA 4-5B 
PHO84a2-920 AGATGAtTTtAAAtGAtTtGGTATAtTtTG 4-5B 
Oligonucleotides that were 32P-end-labeled for primer extension 
CAR1b1-60 CCATTTaAaaaACTCaaaACAATaTaaaAC 4-2D 
PHO5b1-751 TaTTTTCTCATaTAAaCaaACaTCaTCT 4-2AB (upper panel), 4-2C 
PHO5b1-969 AACaCAACTaCACAATaCCAA 4-2B (lower panel) 
PHO5a1-22 CCAAATaaaTATATaCCTTaCCAAaTAAaaTaACC 4-3 (UASp1) 
PHO5a1-20  aaCTAaTTTaCCTAAaaaAATaaTACCTaCATTaaCC 4-3 (UASp2) 
PHO5b1-768  ATATATCTCGAGGACTAATAaAAaAAAACAAaAaACTCCaT 4-4 
PHO8b1-248  AaAATCAAaTAAaACCTCAAaA 4-5A 
PHO84a1-918 ATaTTACCACCTTCaaTAAaaTaTTCTTTATaAA 4-5B 
Pairs of ‘a’ (a1 and a2) or ‘b’ (b1 and b2) are PCR amplification primers for the upper and lower DNA strands, respectively, from 
bisulfite-treated DNA. Nucleotides in lower case represent either G to a or C to t transitions. 
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Chromatin immunoprecipitation (ChIP) analysis  
Strains LFY2152 (3Myc-PHO4) and ADY2398 (PHO4) were grown for 4 h 
in the above minimal medium (2% glucose) containing the indicated 
concentrations of Pi before treatment with 1% paraformaldehyde for 15 min at 
room temperature. ChIP analysis was performed as previously described (Hecht 
and Grunstein, 1999) using 2 µl rabbit A-14 anti-Myc antibody (Santa Cruz 
Biotechnologies). Two microliters of immunoselected and input DNA (1:2000 
dilution) were amplified in the presence of 10 µCi [α32P]dCTP by quantitative, 
competitive PCR with primers ADO236 (CATGTAAGCGGACGTC) and LFO740 
(GCCTTGCCAAGTAAGGTGAC), which simultaneously amplify both the wild-type 
(298 bp product) and mutant (198 bp product) copies of the PHO5 promoter. 
Radiolabeled PCR products were analyzed by 4% native PAGE. 
 
RESULTS AND DISCUSSION 
Targeting of cytosine methylation by Pho4 in vivo 
m5C has been selectively targeted to oligonucleotides in vitro by fusing C5 
DMTases to heterologous DNA-binding factors (Xu and Bestor, 1997; McNamara 
et al., 2002). To date, however, attempts to reproduce this capability in vivo 
have been unsuccessful (McNamara et al., 2002). As a first step toward 
targeting C5 DNA methylation in vivo, we tested whether a native yeast protein 
could specifically target a C5 DMTase and hence increase m5C levels at 
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promoters in the tractable eukaryote, S. cerevisiae (Fig. 4-1). Yeast does not 
have detectable endogenous m5C and foreign expression of C5 DMTases is 
neither deleterious nor has known effects on gene expression (Kladde et al., 
1996; Xu et al., 1998b). The sequences coding M.CviPI (Xu et al., 1998a) were 
integrated at the end of the PHO4 gene, such that the DMTase is fused to the C-
terminus of Pho4 and the fusion protein is constitutively expressed from the 
endogenous PHO4 promoter (Legrain et al., 1986). Pho4 is a basic helix-loop-
helix transactivator that induces expression of the PHO gene cluster after 
binding as a homodimer to E boxes (CACGTG or CACGTT) when Pi is limiting 
(Oshima et al., 1996). The factor to which M.CviPI is fused is designated the 
targeting factor. Acid phosphatase activity is increased in PHO4-M.CviPI strains 
at least 25-fold after 6 h Pi starvation, as has been observed for wild-type 
strains and those expressing other Pho4 C-terminal fusions (O'Neill et al., 1996; 
Komeili and O'Shea, 1999). Since fusing foreign proteins to DMTases can 
decrease the affinity of the DMTase for its recognition site (Xu and Bestor, 
1997), as a control, we expressed M.CviPI tethered to a mutated version of the 
zinc-finger protein, Zif268, that is severely impaired for DNA-binding activity 
(mut Zif). This ‘free’, non-targeted DMTase controls for the extent of GC 
methylation due to DMTase site preferences in protein-free DNA and 
accessibility in chromatin (Gottschling, 1992; Singh and Klar, 1992; Kladde and 
Simpson, 1994; Kladde et al., 1996; Xu et al., 1998b). 
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 We investigated the Pho4-dependent targeting of M.CviPI to the PHO5 
promoter, a well-studied locus of Pho4 binding, in a PHO4-M.CviPI/PHO4 strain. 
The use of a heterozygote rigorously tests whether Pho4 can target the DMTase 
in the presence of wild-type Pho4, and more closely approximates the 
experimental conditions likely to be employed if TAGM were used in vertebrate 
cells. Relative methylation frequencies at multiple GC sites were determined by 
bisulfite genomic sequencing (Frommer et al., 1992; Clark et al., 1994; Kladde 
et al., 1996), where the extent of primer extension termination is directly 
proportional to the level of m5C at a given GC site. PHO4 expression is 
constitutive (Legrain et al., 1986); in high Pi medium, Pho4 is phosphorylated by 
the nuclear cyclin-CDK Pho80-Pho85 and is exported to the cytoplasm thereby 
leading to the repression of PHO genes (O'Neill et al., 1996). Consistent with the 
predominantly cytoplasmic localization of Pho4 under conditions of high Pi, on 
the lower DNA strand of the nucleosome-free region of the PHO5 promoter 
(Almer et al., 1986), C5 methylation by Pho4-M.CviPI of six GC sites (sites 1, 4, 
19, 26b, 41, and 43) is at background levels (Fig. 4-2A, lanes 8 and 9). 
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Figure 4-2. Pho4 specifically targets M.CviPI to the PHO5 promoter. 
(A) Cultures expressing Pho4-M.CviPI and Pho4 or mut Zif-M.CviPI as a free DMTase control were grown 
under repressive conditions in high Pi medium then washed and transferred to Pi-free medium to activate 
PHO genes. Genomic DNA isolated from cells removed at the indicated times was analyzed for m5C levels 
at GC sites on the lower strand of the PHO5 promoter by a bisulfite genomic sequencing. The locations of 
the two known Pho4-binding sites (filled bars), the UASp1 E box, and UASp2 E box, as well as positioned 
nucleosome –2 (partial ellipse), are shown. The distance (base pairs) of each GC site from the respective 
proximal edge of UASp1 in the nuclease hypersensitive region (GC sites from –405 to –331 relative to the 
PHO5 ATG) or UASp2 (GC sites from –290 to –241) are also indicated on the right. The same number of 
total counts was loaded in each lane. In strains expressing either DMTase fusion, the ratios of m5C 
between several sites ( ) in a given lane were similar, identifying sites to which methylation is nontargeted 
or targeted indirectly. Normalization of m5C levels to an accessible histone-free site remote from UASp1, 
site 43 ( ), enables lane-to-lane comparisons and demonstrates protection against methylation ( ) as 
well as efficient targeting of M.CviPI to three GC sites (*) by bound Pho4. Selective targeting of m5C to 
these latter three sites is highly reproducible, as evidenced in lanes 9–17 and in five additional experiments 
analyzing one +Pi and a 4-h -Pi sample. Note that, after 2 h, high levels of methylation in the Pho4-M.CviPI 
samples lead to considerable departure from single-hit kinetics and underestimation of signal intensity.  
(B) Quantitative scans of bisulfite genomic sequencing data. (Upper) Selected lanes (as indicated) in (A) 
are scanned (PHO5 UASp1). Methylation levels can be normalized to that at site 43. (Lower) Scans (PHO5 
UASp2) were obtained by re-extension of the same PCR products used in the analysis in (A) with primer 
PHO5b1–969 that anneals between sites 26b and 37. 
(C) Initial rates of methylation are linear. Quantification of absolute m5C frequencies (percentage of total 
summed product intensities) of the indicated sites from the data in (A), lanes 10–13.  
(D) M.CviPI is specifically targeted by Pho4 to PHO5 and not to CAR1 at early times after PHO activation. 
CAR1 sequences (+159 to +558) were amplified from a subset of the bisulfite-treated samples analyzed in 
(A) and analyzed for m5C levels. The ratios among eight additional sites are also identical. 
(E) TAGM detects Pho4 binding more sensitively than ChIP analysis. Immunoselected (lanes 2–5) and 
nonimmunoselected (lane 1, input) samples from either wild-type PHO4 (lane 5, no tag) or 3Myc-PHO4 
(lanes 2–5) strains that contain a wild-type PHO5 promoter and a mutated promoter (pho5 UASs) were 
analyzed by competitive PCR. The folds of enrichment, normalized to the input ratio, are given. 
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During a time course of PHO transactivation (Fig. 4-2A, –Pi, lanes 11-17), 
methylation at most nucleosome-free sites (sites 13, 19, 26a, 26b, 41, and 43) 
in the PHO5 promoter increased over time in the Pho4-M.CviPI strain, in 
agreement with the well-known nuclear accumulation of Pho4 under these 
conditions (O'Neill et al., 1996). In contrast, in the mut Zif-M.CviPI control strain 
(Fig. 4-2A, lanes 1-7), methylation remained rather constant at most of these 
sites in this histone-free region, except at sites 1 and 4 adjacent to UASp1, 
which are probably protected against methylation by bound Pho4 (Kladde et al., 
1996; Xu et al., 1998b). Closer analysis of m5C levels during 0-2 h after 
activation (Fig. 4-2A, lanes 10-13) indicates that Pho4 predominantly targets 
M.CviPI to PHO5 sites 13 and 26a (asterisked), achieving enrichments of up to 
20- and 34-fold, respectively, over mut Zif-M.CviPI. Directly targeted 
methylation is readily identifiable by inspecting for peak areas that are altered 
relative to other peaks in a given lane with Pho4-M.CviPI as compared to mut 
Zif-M.CviPI (Fig. 4-2B). Further, in the PHO4-M.CviPI strain, methylation 
frequencies of sites 13 and 26a increase linearly from 7 to 23% between 0 and 
2 h (Fig. 4-2A, lanes 10-13; Fig. 4-2C), and plateau at 4 h after induction (Fig. 
4-2A, lane 14). By comparison, from 0-2 h activation, m5C accumulates at an 8-
fold slower rate at site 43 than at sites 13 and 26a (Fig. 4-2C). In addition, 
similar ratios of m5C levels among GC sites in a given lane at an extragenic locus 
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(CAR1), which lacks Pho4 sites, demonstrate that the enhanced methylation of 
sites 13 and 26a at PHO5 is due to site-specific DNA binding by Pho4 (Fig. 4-
2D). These results suggest that the frequency of targeted m5C parallels the 
increase in Pho4 binding to UASp1 that occurs when cells are starved for Pi 
(Svaren et al., 1994; Venter et al., 1994). We conclude that M.CviPI is efficiently 
and directly targeted (see Fig. 4-1) to C residues of GC sites 13 and 26a on the 
lower strand of the PHO5 promoter, which agrees well with the optimal distance 
range of 10-40 bp observed for targeting DNA DMTases to oligodeoxynucleotide 
substrates in vitro (Xu and Bestor, 1997; McNamara et al., 2002). It is likely that 
the DMTase can reach sites within this distance range when the targeting factor 
(i.e., Pho4) is specifically bound to its UAS. Interestingly, other sites, e.g., site 
19, are not selectively modified by Pho4-M.CviPI (Fig. 4-2A-B). 
Indirect targeting of M.CviPI, Pho4-dependent accumulation of m5C that 
occurs locally when Pho4 dissociates from its UAS, is also observed (see Fig. 4-
1). For instance, methylation at sites 41 and 43 increases abruptly at 4 h –Pi and 
continues to rise for the remainder of the time course (Fig. 4-2A, lanes 14-17). 
Moreover, while m5C amounts introduced by Pho4-M.CviPI at PHO5 (e.g., sites 
41 and 43) surpass those attained with the free DMTase (Fig. 4-2A, compare 
lanes 14-17 to 3-7), the converse occurs at the extragenic CAR1 locus at all 
times until 16 h post-induction (Fig. 4-2D, compare lanes 3-4 to 6-10). This 
demonstrates that, at early times after induction, Pho4 preferentially targets 
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M.CviPI to PHO5, and, at extragenic loci, at least 4 h more is required to 
accumulate high levels of m5C. Therefore, at ≥4 h in Pi-free medium (Fig. 4-2A, 
lanes 14-17), the significant increases in methylation at PHO5 sites 41 and 43 
are due to indirect targeting of M.CviPI; Pho4-M.CviPI dissociating from either 
UAS creating a local region of m5C. 
Between 2-16 h induction, Pho4-M.CviPI also increased m5C levels 
substantially at PHO5 sites 7a, 7b, and 37 located in positioned nucleosome –2 
(Almer et al., 1986) (Fig. 4-2A, lanes 13-17). Since nucleosomes block 
accessibility of DMTases (Kladde and Simpson, 1994; Kladde et al., 1996; Xu et 
al., 1998b), the increased methylation of these sites by both M.CviPI fusion 
proteins is indicative of nucleosomal disruption concomitant with PHO5 
activation (Almer et al., 1986). Methylation by mut Zif-M.CviPI at site 37 in the 
presence of Pi (Fig. 4-2A, lane 1) occurs because DMTases can access two 
helical turns of DNA that enter and exit nucleosomes (Kladde and Simpson, 
1994; Kladde et al., 1996; Xu et al., 1998b). Note that methylation levels at 
sites 7a, 7b, and 37 in the Pho4-M.CviPI samples (Fig. 4-2A, lanes 13-17) are 
substantially underestimated due to high levels of primer extension termination 
at sites closer to the primer (i.e., the analysis does not satisfy single-hit kinetics 
at the most primer distal sites). Thus, extension with a primer annealing just 
downstream of site 26b demonstrates that Pho4-M.CviPI methylates sites 7a, 
7b, and 37 more efficiently than mut Zif-M.CviPI (Fig. 4-2B, lower panel). The 
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extensive methylation of these sites by Pho4-M.CviPI is consistent with the high 
level of indirect targeting of methylation to the UASp1 region that occurs ≥4 h Pi 
starvation. In addition, the marked increase in m5C at site 7a relative to 7b with 
Pho4-M.CviPI, and not with mut Zif-M.CviPI, strongly suggests that Pho4 targets 
the DMTase to site 7a after binding UASp2 and/or from a distance when bound 
at UASp1. Therefore, m5C is targeted to the central region of nucleosomes, 
which is inaccessible to DMTases, only when they have been disrupted. 
Strikingly, methylation is targeted directly to several GC sites when the 
majority of Pho4-M.CviPI is expected to be excluded from the nucleus (O'Neill et 
al., 1996). This is evidenced by the significant level of methylation that is 
present at sites 13 and 26a in the presence of Pi (Fig. 4-2B, PHO5 UASp1, 
compare the scan 8 to scans 1 and 6). After normalization of m5C levels to a 
histone-free site, site 43, greater than 20-fold enrichments in targeting of 
M.CviPI to sites 13 and 26a by Pho4 is observed, as compared to the free 
DMTase, mut Zif-M.CviPI. Significant methylation is also targeted under 
repressive conditions to the opposite strand of the PHO5 promoter (Fig. 4-3, 
scan 3). A possible explanation for targeted methylation under repressive 
conditions is that the DMTase fusion impairs the ability of Pho80-Pho85 to 
phosphorylate Pho4, and hence increases the nuclear retention of Pho4-M.CviPI. 
This is unlikely as acid phosphatase expression is not derepressed in the Pho4-
M.CviPI strain. Nevertheless, we tested this possibility further by comparing the 
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rate at which PHO5 transcript levels decrease in wild-type and Pho4-M.CviPI 
strains after adding Pi back to cultures subjected to 10 h Pi starvation. For both 
strains, PHO5 transcript levels decreased by 90% within 20 min of Pi addition, 
indicating that Pho4 and Pho4-M.CviPI are regulated similarly (data not shown). 
Thus, TAGM detects Pho4 binding, even under repressive conditions where its 
nuclear concentration is low (O'Neill et al., 1996), and therefore, promoter 
occupancy by Pho4 is very low. Repeated attempts to detect Pho4 binding in the 
presence of Pi by ChIP analysis were unsuccessful (Fig. 4-2E, lane 2); significant 
immunoselection of Pho4 crosslinked to PHO5 was only detected upon 
transactivation (Fig. 4-2E, lanes 3 and 4). 
 
 
Figure 4-3. Targeting of C5 methylation by Pho4-M.CviPI to the upper strand of the PHO5 promoter. 
The same bisulfite-treated samples used in the analysis in Figure 4-2A were used in the PCR amplification. 
Scans of the phosphorimage of the gel that was loaded with the same number of total counts per lane are 
shown. (Left) The brackets above scans 1 and 3 (PHO5 UASp1) indicate a nonspecific primer extension 
pause that occurred in samples 1–5 or only sample 3, respectively. 
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We also analyzed m5C levels on the upper strand of the PHO5 promoter 
(Fig. 4-3). After transactivation, methylation is enhanced at several GC sites 
near UASp1 (site 87) and UASp2 (sites 7a, 52, 58, 154, 156, and 167), as 
expected with the increased access of both DMTase fusion proteins that 
accompanies nucleosome disruption (Almer et al., 1986). Methylation amounts 
are significantly altered at sites 13, 26b, 7b, and 93 (asterisked) relative to other 
sites in cells expressing Pho4-M.CviPI (scans 3-5) as compared to the control, 
mut Zif-M.CviPI (scans 1 and 2), indicating Pho4-dependent targeting of 
M.CviPI. Interestingly, despite the high level of m5C targeted to sites 7a and 26a 
on the lower strand (Fig. 4-2), M.CviPI is not directly targeted to these sites on 
the upper strand. The reason for this strand-specific, targeting of m5C to pairs of 
GC sites that symmetrically flank each Pho4 binding site (7 or 26 bp away) is not 
understood. 
 
Pho4 targets M.CviPI at a distance  
In Figure 4-3, the marked methylation of site 93 as compared to other 
sites on the upper strand of the PHO5 promoter suggests that M.CviPI is 
targeted at distances (93 bp from UASp2 and 202 bp from UASp1) well beyond 
the optimal targeting distance of 10-40 bp observed in vitro (Xu and Bestor, 
1997). To investigate this possibility further, we determined methylation levels 
at GC sites farther upstream in the PHO5 promoter (Fig. 4-4). m5C levels at a 
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number of GC sites increased at the positions of two additional nucleosomes (−3 
and −4) that are known to be perturbed upon promoter activation (Almer et al., 
1986) (Fig. 4-4A, compare lane 2 to 1 and lanes 6-9 to 3). m5C was reproducibly 
enriched at a GC site located 335 bp from UASp1, in the PHO4-M.CviPI as 
compared to the mut Zif-M.CviPI strain, suggesting the formation of long-range 
interactions stemming from higher order chromatin folding (Fig. 4-4A-B, 
compare lanes 7-9 to 2). A DNA-bound homodimer of Pho4 similarly targets 
M.CviPI distally (60, 78, and 91 bp) to a low affinity Pho4 binding site (UAS E) in 
the PHO84 promoter (Ogawa et al., 1995) (Fig. 4-5B). The Gal4 DNA-binding 
domain- and TetR-Dam DMTase bound at 14 and 112 sites, respectively, can 
also distally target a tethered Dam DMTase (van Steensel and Henikoff, 2000). 
Thus, in comparison to a free DMTase control, TAGM can discern activation-
dependent perturbations in nucleosome structure and preferential DMTase 
targeting at a distance. 
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Figure 4-4. Pho4 targets M.CviPI at a distance. 
(A) Determination of m5C levels upstream of PHO5 UASs. PHO5 sequences were amplified from a 
subset of the bisulfite-treated samples analyzed in Fig. 4-2A to assay for m5C levels. The two 
asterisks at the top of the gel indicate sites 13 and 26a that are directly targeted by Pho4-
M.CviPI near UASp1. Symbols are as in Fig. 4-2A, except that double ( ) and triple GC sites (
) that did not resolve during electrophoresis are also indicated. Site 319 used for 
normalization in (B) is marked as well ( ). 
(B) Quantification of preferential targeting of M.CviPI by Pho4 to site 335, but not to site 278. 
The mean ± standard error of m5C levels for the indicated sites (normalized to site 319) for mut 
Zif-M.CviPI (n = 3) and Pho4-M.CviPI (n = 6) is shown. 
 
Pho4 targets M.CviPI to additional PHO promoters  
Pho4 targeted M.CviPI directly to several GC sites at the PHO8 and 
PHO84 promoters (Fig. 4-5). For example, in contrast to mut Zif-M.CviPI cells, 
yeast expressing Pho4-M.CviPI exhibited significantly higher levels of m5C at 
PHO8 sites 13, 51, and 54 as compared to site 17, and at PHO84 sites 19 and 
36 relative to site 11 (compare the relative peak areas of scans 3 and 4 in (A) or 
3-5 in (B) to those of 1 and 2). Pho4 also significantly targets M.CviPI to each of 
these sites under repressive conditions when Pho4 binding is very low (scan 3). 
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In addition, after starving PHO4-M.CviPI cells for Pi (scan 4 in (A)), amounts of 
methylation at PHO8 sites 24 and 34 in disrupted nucleosome –4 surpass those 
at site 17. While M.CviPI targeting was evident near UASp2 of PHO8, none of 
four GC sites located 11-42 bp from the putative UASp1 is targeted in the 
repressed or activated promoter (data not shown). This indicates further that 
UASp2 is the only functional Pho4 binding site in the PHO8 promoter 
(Münsterkötter et al., 2000). After 2 h activation, methylation at PHO84 sites 60, 
78, and 91 exceeds that at neighboring sites 118, 140, and 221 with Pho4-
M.CviPI, but not mut Zif-M.CviPI (Fig. 4-5B, compare scan 5 to 2). This suggests 
that bound Pho4 directly targets M.CviPI to distal PHO84 sites 60, 78, and 91. 
We conclude that the native transcription factor Pho4 can efficiently target 
M.CviPI to each of the endogenous, single-copy PHO promoters that we have 
tested. 
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Figure 4-5. M.CviPI is targeted by Pho4 to the PHO8 and PHO84 promoters. 
 m5C levels were determined at PHO8 (A) and PHO84 (B) from cells expressing either mut Zif- or 
Pho4-M.CviPI grown in the presence (+) and absence (-) of Pi, as indicated. Shown are the 
quantitative scans of the phosphorimage obtained from the gel (same total counts per lane). GC 
sites to which M.CviPI directly targeted methylation (*), GC sites protected against methylation 
( ), and Pho4-binding sites (filled bars), are labeled. m5C levels can be compared with the sites 
marked with arrows. The positions of nucleosomes (nuc -3 and nuc -4, partial ellipses), 
previously mapped at PHO8 (41), are shown. From the data in (B), we infer the disruption of 
two nucleosomes in the analyzed PHO84 region (increased methylation on activation at seven 
GC sites, 36–221 bp from UAS E; compare scan 2 to scan 1 in (B)). To augment peak heights, 
quantification of the run-off products has been omitted. A region in scan 5 where the signal is 
underestimated due to departure from single-hit kinetics is bracketed. 
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CHAPTER V 
SITE-SELECTIVE IN VIVO TARGETING OF CYTOSINE-5 DNA METHYLATION BY 
ZINC-FINGER PROTEINS‡ 
 
OVERVIEW 
Cytosine-5 DNA methylation is a critical signal defining heritable 
epigenetic states of transcription. As aberrant methylation patterns often 
accompany disease states, the ability to target cytosine methylation to 
preselected regions could prove valuable in reestablishing proper gene 
regulation. We employ the strategy of Targeted Gene Methylation (TAGM) in 
yeast, which has a naturally unmethylated genome, directing de novo DNA 
methylation to select genomic sites via the fusion of C5 DNA methyltransferases 
to heterologous DNA-binding proteins. The zinc-finger proteins Zif268 and Zip53 
can target DNA methylation by M.CviPI or M.SssI 5-52 nucleotides from single 
zinc-factor binding sites. Modification at specific GC (M.CviPI) or CG (M.SssI) 
sites is enhanced as much as 20-fold compared to strains expressing either the 
free enzyme or a fusion protein with the zinc-finger protein moiety defective for 
DNA binding. Interestingly, methylation is also selectively targeted as far as 353 
nucleotides from the zinc-finger protein binding sites, possibly indicative of 
                                                 
‡ The work presented in this Chapter has been published in the following paper: Carvin, C.D., 
Parr, R.L., and Kladde, M.P. (2003). Site-selective in vivo targeting of cytosine-5 DNA 
methylation by zinc-finger proteins. Nucleic Acids Res. 31, 6493-6501 by permission of Oxford 
University Press, Copyright 2003. 
   
 
68
 
 
 
higher-order chromatin structure. These data demonstrate that methylation can 
be targeted in vivo to a potentially broad range of sequences using specifically 
engineered zinc-finger proteins. Further, the selective targeting of methylation 
by zinc-finger proteins demonstrates that binding of distinct classes of factors 
can be monitored in living cells. 
 
INTRODUCTION 
Methylation of the C5 atom of cytosine in DNA (m5C) plays an important 
role in establishing correct patterns of gene expression in vertebrates, usually 
through repression of transcription. Mechanistically, one way DNA methylation 
can lead to transcriptional silencing is by decreasing the binding affinity of a 
transcriptional activator for its site (Attwood et al., 2002). The introduction of 
m5C at sites adjacent to a factor binding site can also interfere with binding (Zhu 
et al., 2003). Perhaps more importantly, symmetrical methylation of CpG 
sequences (CG) serves as a signal for the recruitment of a family of methyl-CpG 
binding domain (MBD) proteins, such as MeCP2 and MBD2 (Wade, 2001). In 
turn, MBDs, either by themselves or as components of complexes, are known to 
recruit a variety of co-repressors, such as histone deacetylases (Jones et al., 
1998; Nan et al., 1998; Wade et al., 1999; Zhang et al., 1999), histone H3 
lysine-9 methyltransferases (Jackson et al., 2002), and heterochromatin coating 
factors like HP1 (Fuks et al., 2003), which can function to establish a local, 
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repressed region of chromatin (Pikaart et al., 1998; Schubeler et al., 2000; 
Lorincz et al., 2001; Lorincz et al., 2002; Mutskov et al., 2002; Irvine et al., 
2002). This silencing mechanism is also conserved in plants, as the DNA 
chromomethyltransferase CMT3, which methylates CNG residues, interacts with 
HP1 to facilitate heterochromatin formation (Jackson et al., 2002).  
 While regions of m5C are often associated with hypoacetylation of 
histones H3 and/or H4 and altered chromatin structure (Pikaart et al., 1998; 
Schubeler et al., 2000; Lorincz et al., 2001; Lorincz et al., 2002; Mutskov et al., 
2002; Irvine et al., 2002), recent evidence suggests DNA methylation- and 
histone deacetylase-independent modes of silencing. First, trichostatin A (TSA), 
a specific inhibitor of histone deacetylation, fails to reactivate transcription from 
densely methylated DNA (Cameron et al., 1999a; Schubeler et al., 2000; Lorincz 
et al., 2001; Magdinier and Wolffe, 2001; Mutskov et al., 2002; Zhu et al., 
2003). Additionally, mbd2-null mice are viable and fertile (Hendrich et al., 2001) 
and Mecp2-null mice only display neurological abnormalities (Guy et al., 2001), 
questioning their global role in m5C-mediated silencing and cellular 
differentiation. Moreover, purified MeCP2 itself compacts reconstituted 
chromatin in the absence of DNA methylation (Georgel et al., 2003). 
 Although the mechanisms are not yet fully understood, there is a strong 
correlation between promoter methylation and gene silencing (Robertson, 2001; 
Jones and Baylin, 2002; Attwood et al., 2002; Bird, 2002). Moreover, once a 
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methylation state is established, it is maintained heritably after many 
generations of replication (Stein et al., 1982) by the maintenance DMTase, 
DNMT1 (Bestor, 2000). An exception includes enhancer sequences that can be 
passively demethylated on replication and subsequent blockage of DNA 
methyltransferase (DMTase) access by factor binding (Kladde et al., 1996; Xu et 
al., 1998b; Hsieh, 1999; Lin et al., 2000; Lin and Hsieh, 2001). However, this 
enhancer-specific loss of DNA methylation does not lead to derepression (Kladde 
et al., 1996). 
 Proper regulation of gene expression is essential for normal cellular 
functions and the avoidance of disease states. DNA methylation, which occurs 
almost exclusively at CG dinucleotides in non-diseased cells, is localized to 
precise regions of the genome, usually in transposons and retroviral elements 
(Bestor, 2000). In contrast, CG sites in euchromatic regions, most notably when 
concentrated in CpG islands, are generally unmethylated and are correlated with 
transcriptional activity. However, in cancer and other diseases, patterns of DNA 
methylation are frequently aberrant. For instance, the DNA in tumor cells is 
generally hypomethylated relative to that in normal cells (Feinberg and 
Vogelstein, 1983), which may lead to genomic instability (Jones and Baylin, 
2002). In contrast, a number of tumor-suppressor genes, including BRCA1 and 
retinoblastoma (Rb), become hypermethylated and transcriptionally inactive 
(Robertson, 2001). The presence of a single methylated CG site in a gene’s 
   
 
71
 
 
 
promoter is sufficient to repress its activation (Robertson et al., 1995), although 
higher m5C density increases the probability of establishing gene repression 
(Boyes and Bird, 1991; Boyes and Bird, 1992; Hsieh, 1994; Cameron et al., 
1999b; Lorincz et al., 2002). Thus, DNA methylation can be critical in defining 
the expression state of a gene. 
 Therefore, directing DNA methylation to improperly regulated loci could 
be used to reestablish proper gene expression through silencing. Previously, 
targeting of C5 methylation has been demonstrated in vitro (Xu and Bestor, 
1997; McNamara et al., 2002), however, selective enrichment of m5C was not 
observed in vivo (McNamara et al., 2002). Recently, in yeast, using the 
dinucleotide-specificity DMTase M.CviPI (Xu et al., 1998a) fused to the basic 
helix-loop-helix activator Pho4, we demonstrated specific targeting of cytosine 
methylation to promoters containing Pho4 binding sites (targeted gene 
methylation; TAGM) (Carvin et al., 2003a). Methylation was efficiently targeted 
to GC sites in nucleosomes that were disrupted on promoter activation, as well 
as to histone-free regions. 
In its present form, targeting DNA methylation is limited to known factors 
that bind to well characterized DNA binding sites, which are often present in 
multiple copies in the genome. Toward achieving the ability to methylate one or 
a small subset of chromosomal regions, herein, we target M.CviPI (GC 
methylation) and M.SssI (CG methylation) by their fusion to zinc-finger proteins, 
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Zif268 and its engineered derivative Zip53, which binds p53 sites (Greisman and 
Pabo, 1997). We detect de novo methylation that is enriched at specific CG or 
GC sites both near and several hundred nucleotides away from their respective 
binding sites. The ability to use zinc-finger modules, which, in principle, may be 
selected to recognize any desired DNA sequence, greatly enhances the range of 
sequences to which m5C can be directed and could lead to novel therapeutic 
approaches. 
 
MATERIALS AND METHODS 
Plasmids, yeast strains and growth conditions 
All yeast strains used in this study were derived from the S288C 
background strain YPH500∆L (MATα ade2-101 ura3-52 his3-∆200 leu2-∆1 trp1-
∆63 lys2-∆1) (Kladde et al., 1996). Zinc-finger coding sequences were PCR 
amplified using the primers MKO46 
5'-GCACTAGTTAGGCCAGCTGGGCCATGGCTGATATCGGATCTGG-3' and MKO47  
5'-GAATAATTCGAGCGCTTTCAAGGTCATGGTGGATCCTAGGCCACCTCCACTCC-3' 
and cloned between SfiI and AfeI restriction sites as in-frame fusions to either 
M.CviPI or M.SssI in pMPK1. The fusion proteins are expressed under control of 
the GAL1 promoter after integration at LYS2 as previously described (Kladde et 
al., 1996). Each N-terminal zinc-finger protein is separated from the DMTase by 
a G(SGGGG)2SGGGLGST (GS linker) peptide (Xu and Bestor, 1997). As a free 
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DMTase control, mutated Zif268 (mut Zif), which contains a single amino-acid 
substitution (H58E) (Nardelli et al., 1991) that ablates DNA binding, was 
constructed by overlap site-directed mutagenesis using the primers MKO72 5'-
CAGTCGTAGTGACgAgCTTACCACCCAC-3' and MKO73 
5'-GTGGGTGGTAAGcTcGTCACTACGACTG-3' (mutated residues in lower case). 
Cells were pre-grown in yeast extract (Difco)/peptone (Difco)/2% dextrose 
(YPD) medium and then washed and resuspended at an OD600 of 0.5 in YP/ 
2% galactose (YPG). After resuspension in YPG, cells were incubated at 30° C 
for 16 h, or for the indicated times. 
 
Bisulfite genomic sequencing 
Total genomic DNA was rapidly isolated by the phenol/chloroform lysis 
method (Adams et al., 1997) and analyzed by bisulfite genomic sequencing 
(Frommer et al., 1992; Clark et al., 1994) as previously modified (Kladde et al., 
1996). PCR amplification from bisulfite-treated genomic DNA with the indicated 
primer pairs was performed with Jumpstart Taq DNA polymerase (Sigma) and 
the resulting products were subjected to primer extension using a 32P-labeled 
oligonucleotide as described previously using final concentrations of 5 µM dATP, 
dCTP, and dTTP (dGTP omitted) as well as 50 µM ddGTP (Kladde et al., 1996) 
(Figs. 5-1 and 5-2), or with dNTPs (A, C, T) and ddGTP increased to 50 µM and 
150 µM, respectively (Figs. 5-3-5) as recently reported (Carvin et al., 2003a). 
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Product intensities were determined by ImageQuaNT software (Molecular 
Dynamics) after subtracting the local background average. Absolute frequencies 
of cytosine methylation were obtained by dividing the intensity of a given band 
by all summed product intensities in a given lane, including the run-off product 
at the top of the gel generated by primer extension on templates lacking 
cytosine residues (i.e., templates not methylated in vivo). Oligonucleotides used 
for PCR amplification of bisulfite-treated DNA are described in Table 5-1 using 
the original naming conventions of Frommer et al. (Frommer et al., 1992). 
 
RESULTS AND DISCUSSION 
In vivo targeting of C5 DMTases near single, Zif268 binding sites 
m5C has been selectively targeted in vitro by fusing C5 DMTases (M.HhaI, 
M.HpaII, and M.SssI) to zinc-finger DNA-binding factors (Xu and Bestor, 1997; 
McNamara et al., 2002). However, attempts to use zinc-finger proteins as 
targeting entities in vivo have been unsuccessful (McNamara et al., 2002). As a 
first step toward targeting DNA methylation in vivo using zinc-finger proteins, 
we tested whether we could increase cytosine methylation levels adjacent to 
zinc-finger protein binding sites (ZBS) in the genetically tractable eukaryote, 
S. cerevisiae. Yeast genomic DNA does not contain detectable levels of 
endogenous methylated residues (Proffitt et al., 1984) enabling unambiguous 
detection of de novo DNA methylation. Also, low-level expression of C5 DNA  
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methyltransferases in yeast has no known effects on gene expression or growth 
(Singh and Klar, 1992; Kladde et al., 1996; Xu et al., 1998b). 
 Since chromatin blocks access of DMTases to their target sites 
(Gottschling, 1992; Singh and Klar, 1992; Kladde and Simpson, 1994; Kladde et 
al., 1996; Xu et al., 1998b), our efforts to target m5C in vivo focus on the use of 
enzymes that methylate dinucleotide sites. This substantially increases the 
probability that DMTase target sites located in accessible, histone-free regions 
will be modified. Either of two C5 DMTases, M.CviPI (GC specificity) (Xu et al., 
1998a) or M.SssI (CG specificity) (Renbaum et al., 1990), was tethered to the 
archetypal zinc-finger protein, Zif268 (Chavrier et al., 1988) and expressed as a 
single-copy, integrated gene under control of the galactose-inducible GAL1 
promoter. The DNA-binding factor that is fused to the DMTase is designated the 
targeting factor. As a control, we expressed either the untethered DMTase or a 
fusion protein in which the DNA-binding activity of Zif268 was severely impaired 
(Nardelli et al., 1991). Strains expressing these ‘free’ DMTase controls establish 
the level of nontargeted methylation due to enzyme site preferences and 
accessibility in protein-free DNA and chromatin (Gottschling, 1992; Singh and 
Klar, 1992; Kladde and Simpson, 1994; Kladde et al., 1996; Xu et al., 1998b). 
 Endogenous yeast Zif268 binding sites (5'-GCGTGGGCG-3') were 
identified by the PatMatch search engine (Dolinski et al., 2003). We determined 
the relative methylation frequencies at multiple GC (M.CviPI) and CG (M.SssI) 
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sites at the CAR1 locus containing a single, consensus binding site for Zif268 by 
bisulfite genomic sequencing (see Materials and Methods) (Carvin et al., 2003a). 
Specific binding by the Zif268 moiety of each fusion protein is supported by 
protection of multiple CG and GC sites against methylation at the Zif268 site in 
strains expressing a wild-type Zif268 fusion as compared to its respective free 
DMTase (filled bar; Fig. 5-1A-C; compare lane 1 to 2 and lane 3 to 4). Ratios of 
m5C among several sites in a given lane were similar, identifying sites at which 
nontargeted methylation occurs (filled circles), which enable normalization for 
differences in methylation activity between strains. By this criterion, the mut Zif- 
M.CviPI strain has approximately 2-fold more methylation activity than cells 
expressing Zif-M.CviPI. The reason for this activity difference is unclear. DNA 
methylation increased substantially at several sites (asterisks) in cells expressing 
Zif-M.CviPI and Zif-M.SssI versus mut Zif-M.CviPI and M.SssI, respectively, 
demonstrating enhanced targeting of both DMTases by DNA-bound Zif268. 
Targeted modification sites (asterisks) are readily identifiable by normalizing to 
sites of nontargeted methylation (filled circles). Methylation preferentially 
accumulates at four GC sites (asterisks) over a time course of Zif-M.CviPI 
induction by galactose (Fig. 5-1C, lanes 1-6). Our data suggest that m5C accrues 
with increasing synthesis of Zif-M.CviPI from the GAL1 promoter, and 
presumably increased occupancy of the Zif268 site. 
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Figure 5-1. Targeting C5 DMTases near a single Zif268 site. 
(A) Determination of m5C levels targeted by Zif268–DMTase fusions. Genomic DNA isolated from strains 
expressing wild-type Zif268–M.CviPI (Zif–M.CviPI, lane 2), Zif268–M.SssI (Zif–M.SssI, lane 3), or ‘free’ 
DMTase controls, a mutated Zif268 fused to M.CviPI (mut Zif–M.CviPI, lane 1) or M.SssI by itself (lane 4), 
was analyzed by modified bisulfite genomic sequencing of CAR1 from +558 to +159. Distances (bp) of a 
subset of sites from the proximal edge of the Zif268 ZBS (filled bar; +438 to +446) are indicated at left 
and right of the gel. Sites of non-targeted methylation (filled circles). Sites 46 (M.CviPI strains) and 25 
(M.SssI strains) (arrows) were chosen for normalization to enable lane-to-lane comparisons [see (B)]. Each 
DMTase was preferentially targeted to several CG and GC sites (asterisks) by Zif binding as compared with 
its respective control (compare lanes 1 with 2 and 3 with 4). For site 19, 41% (of all summed intensities) of 
the templates in the population are methylated. Lanes T, G and A (left) contain sequencing reactions with 
ddATP, ddCTP and ddTTP, respectively.  
(B) Quantitative scans of the phosphoimage in (A). See (A) for definitions of symbols. 
(C) Time course of targeting M.CviPI by Zif268. Expression of Zif–M.CviPI (lanes 1–6) and Zif–M.SssI (lanes 
7–9) from the GAL1 promoter was initiated by transferring cells from YPD (dextrose) to YPG (galactose) 
medium. Genomic DNA was isolated at the indicated times and analyzed as in (A). Symbols are defined in 
(A). 
(D) Quantification of preferential targeting of M.CviPI by Zif268. Ratios of m5C for the indicated sites 
(normalized to site 46) for Zif–M.CviPI to mut Zif–M.CviPI are given (mean ± standard error; n = 3). 
Similar values are obtained if the ratios for each site are normalized to other sites of non-targeted 
methylation (filled circles) or calculated using absolute frequencies of methylation (see Materials and 
Methods). 
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M.CviPI is targeted most efficiently to a site located 19 bp from the Zif268 
binding site (Fig. 5-1D), which correlates well with the optimal range of 10-
40 bp observed when methylating oligonucleotides with other DMTase fusion 
proteins in vitro (Xu and Bestor, 1997; McNamara et al., 2002) and in yeast 
(Carvin et al., 2003a). This optimal distance for introducing m5C is likely related 
to the length and amino acid sequence of the flexible peptide separating Zif268 
and the DMTase (McNamara et al., 2002). However, targeting methylation distal 
to the Zif268 binding site (e.g., sites 163 and 183) is as or more efficient than to 
some proximal sites (e.g., sites 41, 43, and 52) (Fig. 5-1A-D). Significantly, 
preferential methylation by M.CviPI and M.SssI at sites 163-183 nucleotidesfrom 
the Zif268 binding site (Fig. 5-1A-D) suggests that m5C can be targeted distally, 
perhaps due to the formation of higher-order chromatin structure. A single, 
DNA-bound monomer of Zif268 similarly targets both DMTases close to (5-30 
bp) and at a considerable distance from (353 bp) a second consensus Zif268 
binding site in YBR108W (+2067 to +2075; Fig. 5-2A-B). For a third Zif268 
binding site (–397 to –389 of YOL019W), two GC sites are protected against 
methylation by Zif-M.CviPI bound at the ZBS, and m5C is targeted to an 
additional GC site 39 bp away from the ZBS (Fig. 5-2C). In contrast, the relative 
levels of CG or GC site methylation at the PHO5 promoter, which lacks Zif268 
sites, show no significant differences between the wild-type Zif268 fusion and its 
respective free DMTase control (Fig. 5-3, compare lane 1 to 2 and 3 to 4). We 
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conclude that the targeted methylation is due to site-specific DNA binding by 
Zif268.  
 
 
Figure 5-2. Zif268 targets M.CviPI and M.SssI to additional ZBS. 
(A) Determination of m5C levels. A region of YBR108W (+1564 to +2163) spanning a single 
Zif268 site (+2067 to +2075; filled bar) was PCR amplified from the same bisulfite-treated 
samples analyzed in Figure 5-1A. Sequencing ladders (A, T) are at the right. Symbols are 
defined in the caption to Figure 5-1. 
(B) Scans of the phosphoimage in (A). The scanned lanes are indicated at the left. 
(C) Methylation targeted to a third Zif268 site (filled bar) near YOL019W (–397 to –389). Only 
scans of the phosphoimage resulting from the bisulfite genomic sequencing of the region from –
509 to +254 are shown. 
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Figure 5-3. Absence of site-selective methylation at unlinked loci. 
The PHO5 promoter (–1009 to –205), lacking Zif268 sites, was PCR amplified from the same 
bisulfite-treated samples analyzed in Figures 5-1 and 5-2A to determine levels of m5C. The 
positions of the two known Pho4 transactivator binding sites, UASp1 and UASp2 (open bars), 
localized to a histone-free, DNase I-hypersensitive region and positioned nucleosome –2 (partial 
ellipse), respectively, are indicated. GC (lanes 1 and 2) and CG (lanes 3 and 4) sites (filled 
circles). Note that, relative to the mut Zif–M.CviPI control (lane 1), the lower methylation 
frequencies in the Zif–M.CviPI strain (lane 2) at each GC site is consistent with the conclusion 
that it has reduced overall methylation activity. However, the similar ratios of site intensities 
within lanes 1 and 2 (M.CviPI) as well as within lanes 3 and 4 (M.SssI) demonstrate that m5C 
accumulates independent of the Zif (or mut Zif) fusion moiety. 
 
Targeting M.CviPI via phage display-selected Zip53 
The enginereed zinc-finger protein Zip53, which specifically binds to a 
p53 consensus site (5'-GGGACATGT-3'; hereafter Zip53 binding site) (Greisman 
and Pabo, 1997), was previously fused to M.SssI and used in vitro to target 
methylation next to a Zip53 binding site in an oligonucleotide substrate (Xu and 
Bestor, 1997). To corroborate further our initial methylation targeting studies 
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using Zif268, we tested if Zip53 could direct methylation by M.CviPI to regions 
containing a single Zip53 site in vivo. The Zip53-M.CviPI fusion protein was 
integrated as a single copy at LYS2 and expressed from the GAL1 promoter. 
First, we analyzed C5 methylation levels near the consensus Zip53 binding site 
located in the DED1 coding sequence (Fig. 5-4; +284 to +276). As expected, 
since yeast do not have endogenous cytosine DMTases, no modified cytosines 
are evident in a strain that does not contain a functional copy of M.CviPI (Fig. 5-
4A, lane 4). Normalizing to site 141, relative to the “free” DMTase control 
(mut Zif-M.CviPI), on expression of Zip53-M.CviPI, targeted methylation is 
detected 30 bp from the DED1 consensus Zip53 site (Fig. 5-4A; compare lanes 2 
and 3 to lane 1). Further, long-range methylation at sites 162 and 178 bp from 
the ZBS is substantially enhanced. Lastly, there is reproducible low-level 
protection of a GC site located 3 bp from the ZBS, indicative of Zip53 binding 
(Fig. 5-4A-B). 
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Figure 5-4. The engineered zinc-finger protein, Zip53, targets a DMTase to DED1. 
(A) Determination of m5C levels at DED1 (+475 to +67). Targeted methylation (asterisks), 
normalized to site 141 (arrow), is detected at GC sites 30, 162 and 178 bp away from the Zip53 
binding site (hatched bar) in two Zip53–M.CviPI strains (lanes 2 and 3) that are representative 
of four independent strains containing the integrated Zip53–M.CviPI fusion gene. Filled circles 
indicate remaining CG and GC sites of non-targeted methylation (not selectively methylated) on 
expression of Zip53–M.CviPI. Lanes 1 and 4 contain bisulfite genomic sequencing results from 
the mut Zif–M.CviPI strain and a Zip53–M.CviPI transformant that contains a non-functional 
DMTase, respectively. Sequencing ladders (T, G, A) are at the right. 
(B) Quantitative scans of the phosphoimage in (A). Symbols are defined as in (A). 
 
We also observed long-range targeting of m5C at a second consensus 
Zip53 site located in the YLR016C coding sequence (+298 to +306; Fig. 55-B). 
Methylation was enhanced 5.5-fold at site 184, and somewhat less but 
significantly (~2.2-fold), at sites 157 and 190 in strains expressing Zip53-
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M.CviPI relative to mut Zif-M.CviPI. Protection against DNA methylation could 
not be observed because no GC sites are adjacent to or within the Zip53 binding 
site. To examine the specificity of the Zip53-DMTase fusion protein, we analyzed 
m5C levels at the CAR1 locus (cf. Fig. 5-1), which contains a Zif268 site, but no 
Zip53 site (Fig. 5-5C). In each lane of the gel in Figure 5C, little to no change 
exists in the relative methylation levels of 13 GC sites at CAR1. In particular, 
methylation at site 19 of the CAR1 region, which shows >20-fold enrichment 
following expression of Zif-M.CviPI (Fig. 5-1), is not increased in the presence of 
Zip53-M.CviPI. This result demonstrates that Zip53 specifically binds its site, but 
not that of Zif268 (the two binding sites have 22% identity). We conclude that, 
as for Zif268, Zip53 is able to target M.CviPI and thereby significantly increase 
cytosine methylation at select GC sites near and distal to a cognate ZBS. The 
use of Zip53 to deliver m5C selectively further demonstrates that zinc-finger 
proteins engineered to recognize pre-determined sequences can be used to 
introduce de novo methylation essentially to any region of interest. 
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Figure 5-5. Zip53-mediated targeting of m5C to YLR016C. 
(A) Determination of m5C levels at YLR016C (+418 to +28). Targeted methylation (asterisks), as 
normalized to site 40 (arrow), is detected at GC sites 157, 184 and 190 bp away from the Zip53 
site (hatched bar) in two independent transformants (lanes 3 and 4) relative to mut Zif–M.CviPI 
(lanes 1 and 2). T, G and A sequencing ladders are at the right. Non-targeted methylation (filled 
circles). The sample in lane 5 was obtained from a Zip53–M.CviPI transformant harboring a non-
functional DMTase. 
(B) Quantitative scans of the phosphoimage in (A). 
(C) Determination of m5C levels at the CAR1 locus (+558 to +159) that has a Zif268 binding site 
(filled bar) but no consensus Zip53 binding site. The PCR products analyzed in lanes 1–4 were 
amplified from the bisulfite-treated genomic analyzed in lanes 1–4, respectively, in (A). Lane 5 
contains a sample from a parental strain that was not transformed with M.CviPI. Non-specific 
primer extension pauses that do not correspond to GC sites are marked with brackets. 
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CHAPTER VI 
SUMMARY AND CONCLUSIONS 
 
SET1 AS A NEGATIVE REGULATOR OF GENE EXPRESSION 
Histone methylation at lysine 4 by Set1 via COMPASS is a prominent 
histone modification in yeast. Approximately 35% of nucleosomes contain K4 
methylated histone H3. Recent evidence has demonstrated that Set1-dependent 
methylation requires the monoubiquitination of histone H2B and the Paf1-Rtf1 
complex, which has been implicated in transcriptional elongation through the 
interaction of the C-terminal domain of RNA polymerase II. The fact that K4 
methylation is primarily associated with euchromatic genes while K9 methylation 
is correlated with heterochromatin suggests that each may play an integral role 
in the establishment of active and inactive regions, respectively. In fact, recent 
evidence has shown that K9 methylation via the histone methyltransferase 
Suv39h leads to the recruitment of HP1 (Bannister et al., 2001; Lachner et al., 
2001). Artificial targeting of histone methylation or HP1 via chimeric fusion 
proteins to euchromatic regions leads to local gene silencing (Snowden et al., 
2002; Li et al., 2003). Though K4 methylation via Set1 is associated with active 
chromatin, it is not known if this modification leads to recruitment of other 
factors or what function it may serve. Although it is associated with 
transcriptional elongation and appears to be prominent throughout the promoter 
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regions of euchromatic genes, K4 methylation has been shown to required for 
the full expression of only a few genes (Nislow et al., 1997; Santos-Rosa et al., 
2002). We present evidence that Set1 is involved in the repression of a subset 
of genes in active chromatin regions. We show that the loss of Set1 leads to 
higher levels of the repressible acid phosphatase PHO5 in both repressing and 
activating conditions. This is evidence to demonstrate that K4 methylation may 
have a repressive role in gene expression as well as the previously characterized 
activating role. Our results go further, demonstrating that PHO84 and GAL1-10 
are also expressed higher with the loss of Set1. We confirm that a general 
derepression effect by the set1∆ mutant is not observed since PPH3 is down-
regulated, as has been shown previously (Santos-Rosa et al., 2002). 
 Deletions in components of complexes which regulate Set1 methylation 
also show similar phenotypes as that observed with a SET1 null strain. A strain 
deleted for PAF1, the most upstream regulator, exhibits the largest derepression 
on PHO5, suggesting that other factors are recruited in addition to Set1. It was 
previously reported that a paf1 mutant caused both transcriptional defects as 
well as increased expression, which demonstrates a dual role in gene regulation 
(Shi et al., 1996). Interestingly, in that study, GAL10 and GAL7 were two of the 
genes that required Paf1 for full expression, which again suggests that Paf1-Rtf1 
may recruit additional proteins that might affect gene expression positively or 
negatively. Similarly, a deletion of the carboxyl-terminal domain kinase (CTK1) 
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also had both a positive and negative role in transcription of various genes 
(Patturajan et al., 1999). More recently, the histone methyltransferase Set2, 
which methylates histone H3 at lysine 36, has also been associated with active 
chromatin, transcription elongation via the Paf1-Rtf1 complex and is required for 
full expression of a GAL1-lacZ reporter (Krogan et al., 2003b). However, when 
the Set2 protein is tethered to a heterologous promoter via LexA, it serves as a 
repressor lowering transcription greater than 20-fold (Strahl et al., 2002). 
Consistently, Set2 is responsible for the repression of the basal expression of 
GAL4 (Landry et al., 2003). Taken together, this demonstrates that despite their 
association with transcription elongation, regulators may be positive in a subset 
of genes while negative at others. The mechanism for this remains unclear. 
Histone monoubiquitination of histone H2B at lysine 123 via the Rad6-
Bre1 complex also negatively regulates PHO5. GAL10 is expressed at much 
higher levels in a rad6∆ null; however, the corresponding histone mutant did not 
show the same effect (Daniel et al., 2004). This mutant was also used in 
another study to show that histone ubiquitination is present at GAL1 and PHO5 
and had less than a two-fold effect in transcriptional activation but was 
synergistic with gcn5∆ (Kao et al., 2004). It is unclear why different phenotypes 
are seen between a rad6∆ and histone H2B K123R mutant strains. This may be 
a result of strain differences or because the histone mutant is present on an 
episome, which has inherent expression differences than when integrated. 
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A recent study has identified a potential regulator which links histone 
ubiquitination of histone H2B and histone methylation of histone H3.  Ezhkova 
and Tansey have demonstrated that the proteosomal ATPases Rpt4 and Rpt6 
are required for K4 methylation (Ezhkova and Tansey, 2004).  Rpt4/6 
recruitment is dependent on Rad6 suggesting that histone ubiquitination is 
required.  Further, they showed that a mutation in Rpt6 lead to increased levels 
of GAL10.  The authors state that a strain lacking Set1 also showed a “similar 
phenomenon”, however, the relative effects are not known since the data was 
not shown. These results are consistent with our observations at GAL10.  Future 
studies should examine if similar effects are seen at PHO5.  
Upon PHO5 activation, histone ubiquitination increases only transiently 
for the first 90 minutes of induction (Kao et al., 2004), presumably due to the 
presence of the histone deubiquitination activity of Ubp8 of SAGA (Henry et al., 
2003; Daniel et al., 2004). It is possible since K4 methylation is strictly 
dependent on H2B ubiquitination that its levels will also be transient as well, 
however, no histone demethyltransferase has been discovered. Lower amounts 
of K4 methylation are observed in phosphate-free media than in YPD (Reinke 
and Hörz, 2003), but this may be a result of histone loss.  
We believe that Set1 regulates gene expression positively and negatively. 
The evidence that its methylation activity fully depends on the transcriptional 
elongation complex Paf1-Rtf1 as well as the fact that paf1∆ and rtf1∆ mutants 
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also derepress PHO5 suggests that K4 methylation may serve as a negative 
feedback loop on basal transcription. Future studies should focus on elucidating 
how Set1 mediates this repression. It is likely that K4 methylation may serve as 
a signal to recruit additional co-repressors. HP1, a heterochromatin-associated 
coating factor, can bind to methylated K9 residues via its chromodomain 
(Nielsen et al., 2001; Bannister et al., 2001). In Saccharomyces cerevisiae, there 
is no detectable K9 methylation, however, there is at least one protein which 
actually contains a chromodomain, Chd1 (Woodage et al., 1997). Chd1 is a 
subunit of an ATP-dependent chromatin remodeling complex which has both 
positive and negative roles in transcription (Tran et al., 2000). Additionally, like 
Set1, it is associated with transcriptional elongation (Krogan et al., 2002b) and 
interacts directly with Rtf1 (Simic et al., 2003). Conversely, one study showed 
using yeast two-hybrid and in vitro pull-down assays, that human Chd1 interacts 
with the transcriptional co-repressor NCoR and co-immunoprecipitates with 
HDAC activity (Tai et al., 2003). Alternatively, other co-repressors such as Ssn6-
Tup1 or HDACs may be targeted by Set1. PHO5 expression was increased 
greater than three-fold in a strain lacking TUP1 (Carvin and Kladde, unpublished 
observations), however, other experiments are needed to determine if Set1 and 
Tup1 are part of the same genetic pathway. Delineating what factors are 
involved in dictating this dual regulation of histone methylation will be important 
in characterizing its function. 
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BROMODOMAINS CAN INCREASE THE ACTIVATION ABILITY OF 
TRANSCRIPTION FACTORS 
 In this study, we have shown that fusing the bromodomain to a primary 
activator can increase the ability of the activator to increase transcription. In 
high phosphate, fusion of the Gcn5 bromodomain increases PHO5 transcription 
greater than 8-fold. Mutations in essential residues of the bromodomain 
alleviated this effect. This control rules out the possibility that the addition of the 
bromodomain causes mis-regulation of Pho4 or that the bromodomain may 
contain a cryptic activation domain. 
The fact that we see this enhancement of transcription in repressed 
conditions demonstrates that Pho4 must bind at least transiently in high 
phosphate conditions, as seen previously (Carvin et al., 2003a). The PHO5 
promoter contains significant levels of background histone acetylation that may 
serve as a binding surface for the Gcn5 bromodomain (Vogelauer et al., 2000). 
This additional binding contact could increase the overall binding affinity of the 
fusion factor. Ongoing studies will determine how the promoter occupancy of 
the PHO5 promoter by Pho4 changes in the bromodomain fusion strain. If 
promoter occupancy is increased, this will demonstrate that the bromodomain 
functions to stabilize the recruitment of chromatin remodeling coactivators. The 
interaction of bromodomains with acetylated lysines, a modification correlated 
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with transcriptionally active regions, provides an elegant positive feedback loop 
for the recruitment of coactivators and the transcription machinery.  
 We did not detect significant enhancement of PHO5 expression via the 
bromodomain fusion under fully activating conditions (Fig. 3-2). This could be 
either because the promoter is fully occupied or that gene expression of PHO5 is 
already at its maximum. Overexpression of Pho4 by regulating PHO4 by the 
GAL1 promoter shows that PHO5 expression saturates at very low levels of 
galactose, indicating that PHO5 expression reaches a maximum expression level 
(Hoose and Kladde, unpublished observations). It may also be a result of loss of 
histone acetylation upon activation due to physical removal of the nucleosomes 
(Reinke and Hörz, 2003; Boeger et al., 2003). 
 Ongoing studies will elucidate what contributions the bromodomain 
makes to promoter occupancy. It is difficult to determine the contributions that 
the bromodomain may make to coactivators recruitment in vivo due to 
limitations of the ChIP technique. Enrichments of factors that do not bind DNA 
directly are very poor, usually around 2-fold, making quantification very difficult. 
However, proteins which bind DNA directly are immunoprecipitated rather 
efficiently. For instance, we achieve greater than 25-fold enrichment of Pho4 in 
activating conditions (Dhasarathy, Carvin, Jessen, and Kladde, manuscript in 
preparation). Using our novel BD fusion strategy we expect to be able to obtain 
quantifiable measurements of effect(s) that the bromodomain may have on 
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promoter binding. We will also test the effectiveness of various other 
bromodomains in yeast, including those from the Spt7 subunit of SAGA and 
Swi2 ATPase of the Swi-Snf complex. Previous work using an in vitro system has 
shown that the Spt7 bromodomain can complement loss of the Gcn5 
bromodomain, but only when it is fused to Gcn5 (Hassan et al., 2002). The 
authors argue that bromodomain function may be determined by the subunit it 
is in, and our system should allow us to test this hypothesis.  
 In budding yeast, all of the proteins that contain bromodomains are 
contained in either chromatin remodeling coactivators or the general 
transcription machinery. However, in higher eukaryotes, there are a number of 
site-specific transcription factors that contain putative bromodomains. Also, in 
two different cancer cell lines, there is a fusion of a bromodomain with another 
transcription factor to form oncogenes (Lavau et al., 2000; French et al., 2003). 
There has very little work in determining how the bromodomain may assist the 
transcriptional activity of the factor. Thus, our study will be the first such study 
in characterizing how bromodomains may affect transcription factor binding. By 
constructing myriad of bromodomains fusions (e.g., Swi2, Spt7) to the same 
factor, Pho4, we can determine the relative strength of each bromodomain.  By 
making fusion to a site-specific DNA binding factor, we expect to obtain 
quantifiable measurements on increases in promoter occupancy.  This work 
should elucidate key information into how bromodomains may affect 
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transcriptional activation with potential connections to temporal order of 
chromatin remodeling enzymes and cancer biology. 
 
USING DNA METHYLTRANSFERASES TO SIMULTANEOUSLY DETECT 
DNA-PROTEIN INTERACTIONS AND PROBE CHROMATIN STRUCTURE 
We have demonstrated that TAGM is a highly effective and sensitive 
technique for detecting DNA-protein interactions and activation-dependent 
changes chromatin structure in vivo. The method provides several distinct 
advantages over other available approaches (Simpson, 1999), including: 1) 
identification of sites of factor interaction at relatively high resolution in living 
cells; 2) high sensitivity, requiring only small amounts of cells and detecting 
factor binding even at single, native sites; and 3) the ability to monitor 
nucleosomal rearrangements kinetically. In vitro, the ability to target m5C is 
primarily related to the distance between a particular DMTase site and the factor 
binding site, which is likely related to the length and nature of the peptide 
separating the targeting factor and the DMTase (Xu and Bestor, 1997; 
McNamara et al., 2002). In addition to these constraints, our results 
demonstrate that, in chromatin, the efficiency of targeting m5C to a given site is 
determined by its accessibility, its rotational orientation relative to the factor 
binding site, and/or higher order chromosome structure. 
Taken together, at PHO5, our data suggest that a homodimer of Pho4, 
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initially binding to the accessible UASp1 E box, preferentially targets M.CviPI to 
sites 13 and 26a (Venter et al., 1994). Subsequently, disruption of nucleosome  
–2, presumably mediated by the recruitment of coactivators, such as histone 
acetyltransferases (Gregory et al., 1998; Galarneau et al., 2000) and ATP-
dependent remodelers (Santisteban et al., 1997; Sudarsanam et al., 2000; 
Steger et al., 2002) to PHO5, facilitates Pho4 binding at the high affinity UASp2 
site (Svaren et al., 1994; Venter et al., 1994). Increases in the local DMTase 
concentration due to cooperative binding of Pho4-M.CviPI that accompanies 
chromatin perturbation may account for the accumulation of high levels of 
methylation at sites to which the DMTase is indirectly targeted (e.g., sites 41 
and 43). In that Pho4 targets M.CviPI at a distance, it is interesting to speculate 
that it can also do so with recruited coactivators and hence disrupt distal 
nucleosomes (Kim and Clark, 2002). 
Previous studies have suggested that residual levels of Pho4 are present in 
the nucleus in high Pi (Han et al., 1988; Han and Grunstein, 1988; Wechser et 
al., 1997), despite its predominant cytoplasmic localization under these 
conditions (O'Neill et al., 1996). The presence of marked targeted m5C at PHO5, 
PHO8, and PHO84 provides direct evidence of a low level of Pho4 binding in the 
presence of Pi. This binding occurs either before phosphorylation of Pho4 by 
Pho80-Pho85 or after its modification and prior to subsequent nuclear export. 
The sensitivity of TAGM is underscored by this result because, in the presence of 
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Pi, Pho4 binding is not detectable by ChIP analysis (Steger et al., 2002) or 
genomic footprinting (Venter et al., 1994). Thus, TAGM is a powerful and 
complementary alternative to existing technologies.  
 In addition to the use of TAGM with Pho4 fused to M.CviPI presented 
here, we have also targeted M.CviPI as well as M.SssI, acting on CG sites, both 
near and several hundred nucleotides from single Zif268 as well as p53 binding 
sites (Carvin et al., 2003b). Thus, the successful application of TAGM for these 
three factors tested thus far, each at different loci, validates its efficacy in 
targeting C5 methylation and hence detection of factor interactions. We are 
currently extending TAGM to additional transcription factors and coactivators. 
Currently, detection of coactivators which do not bind to DNA directly is often 
difficult by ChIP. However, we were able to detect targeted methylation 
indicative of Pho4 binding in repressed conditions where we were unable to 
detect such binding by ChIP. I believe this is due to the fact that ChIP is 
technique that can only detect what is bound at the promoter at the time of 
cross-linking while targeted methylation is an accumulation of multiple binding 
events over time.  
Our observation that substantially more methylation by Pho4-M.CviPI at 
PHO5 vs. CAR1 occurs at early times following PHO activation is promising for 
using TAGM in genome-wide identification of targets for Pho4 and other 
transcription factors. McrBC is a restriction enzyme which digests Rm5C sites 
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specifically. We could use this enzyme to digest genomic DNA and purify the 
smaller fragments (methylated) from the larger fragments (nonmethylated) by 
sucrose centrifugation. The enriched DNA fragments could then be fluorescently 
labeled with Cy3 or Cy5 dyes by random priming and hybridized to a DNA 
microarray containing spotted intergenic regions of DNA in order to identify 
other regions where Pho4 may be binding. It is important to note that this 
analysis must be done at early times of activation since significant background 
methylation is observed at later times. I believe this is due to the continual 
build-up of Pho4 in the nucleus when the cells are grown in phosphate limiting 
conditions. Basically, at later times the concentration of Pho4 leads to its 
maximal binding at bona fide Pho4 binding sites and then significant 
nontargeted methylation begins to accumulate. A previous work using the Dam 
DMTase fused to TetR showed that they could only achieve significant 
methylation targeting at TetR binding sites when their concentration of TetR-
Dam fusion was very low (Lebrun et al., 2003). 
Our analysis of Pho4-M.CviPI vs. mut Zif-M.CviPI (Fig. 4-4) showed a site 
of targeted methylation in nucleosome -4, some 335 bp away from the nearest 
UAS. When normalized to nearby site, this site showed nearly three-fold more 
methylation in the Pho4-M.CviPI strain than the free DMTase control. Another 
site that was also contained in nucleosome -4 (site 278) did not show any 
enhanced methylation over the free DMTase. While more analysis is needed to 
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confirm this, the observation of distal targeted methylation could be indicative of 
higher-order chromatin structure. Since chromatin remodeling enzyme 
recruitment is dependent on the primary activator Pho4, this could also explain 
why the distal nucleosomes -4 and -5 are remodeled.  
Our analysis has also provided preliminary evidence regarding another 
question pertinent to our laboratory studies. One of the ongoing projects is to 
determine the temporal order of nucleosome remodeling at the PHO5 promoter. 
Analysis of chromatin remodeling during a time course of phosphate starvation 
using the mut Zif-M.CviPI probe showed that a spreading of nucleosome 
remodeling occurs with nucleosome -3 being fully remodeled earlier than 
nucleosomes -4 and -5 (Jessen, Dhasarathy, Carvin, McKinnie, and Kladde, 
manuscript in preparation). This is being studied in much greater detail by 
another graduate student in the laboratory. 
    
TARGETING CYTOSINE METHYLATION BY USING ENGINEERED ZINC-
PROTEINS 
We extend the ability to target cytosine methylation in vivo using two 
zinc-finger proteins, Zif268 and its artificially engineered derivative Zip53. First, 
significant targeting of cytosine methylation is observed both adjacent (5-52 bp) 
and distal (>150 bp) to the cognate ZBS, whereas DNA methylation is not 
enriched at control loci lacking the ZBS. Proximal and distal targeting of C5 
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methylation was also observed in our previous studies using Pho4 as the 
DMTase targeting factor (Carvin et al., 2003a). The reasons for selective 
targeting of m5C to some sites as opposed to others in the same region are not 
currently understood. At least locally, presumably the length of the peptide 
linker separating the DMTase and the targeting factor, the helical face of a 
particular CG or GC site relative to the DNA-bound targeting factor, and 
accessibility in chromatin each contribute to the preferential targeting. In 
addition, the occurrence of targeted C5 methylation beyond distances of 40 
nucleotides suggests that two sites well-separated in protein-free DNA are 
juxtaposed in the nucleosome or by higher-order chromatin structures (e.g.,  
Fig. 5-2A, 353 bp away from the ZBS). Second, since DNA-bound factors often 
impair access of DMTases to their target sites (Kladde et al., 1996; Xu et al., 
1998b; Hsieh, 1999; Lin et al., 2000; Lin and Hsieh, 2001; Carvin et al., 2003a), 
the protection against methylation of CG or GC sites next to or within the ZBS 
provides further evidence of specific ZBS binding by each zinc-finger-DMTase 
fusion protein. Taken together, in addition to demonstrating selective 
enrichment of m5C near ZBS, TAGM provides a highly sensitive means for 
detecting protein-DNA interactions (Carvin et al., 2003a). Third, accumulation of 
m5C at select sites during a time course of Zif-M.CviPI induction suggests that 
the extent of targeted methylation parallels the cumulative amount of factor 
binding over time. Thus, optimizing occupancy of the targeting factor at regions 
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of interest will likely increase the efficacy of specific m5C targeting in vivo as well 
as lessen nontargeted methylation. The experimental system used herein 
provides a useful assay for pursuing such further investigations. 
 The design of multiple zinc-finger modules with desired specificities is 
proving a versatile platform for targeting a variety of protein moieties to 
accessible sites in vivo (Urnov and Rebar, 2002). For instance, engineered zinc-
finger proteins have been fused to the catalytic domain of FokI endonuclease to 
direct site-specific double-stranded DNA cleavage, and hence homologous 
recombination, of desired regions (Bibikova et al., 2001). Designed zinc-finger 
proteins have also been used to target the catalytic domains of the histone 
methyltransferases G9A and SUV39H1 (Snowden et al., 2002) as well as the 
VP16 activation domain (Zhang et al., 2000; Liu et al., 2001; Rebar et al., 
2002), leading to repression and activation, respectively, of expression of the 
endogenous human erythropoietin (EPO), vascular endothelial growth factor A 
(VEGF-A), and other mammalian genes (Urnov and Rebar, 2002). This 
technology has also recently been extended to the regulation of gene expression 
in plants (Sanchez et al., 2002). 
 The targeting of DMTases by zinc-finger proteins selected to bind specific 
ZBS might provide an additional way to down-regulate the expression of desired 
genes. Moreover, since the DNA methylation state of a given promoter is 
maintained heritably through DNA replication by endogenous cellular 
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mechanisms, an initial targeting event may be sufficient to establish stable 
silencing of improperly expressed genes. Therefore, heritable repression could 
also reduce the amount of treatment necessary to establish the proper 
regulation of a particular gene. In addition to providing a potentially powerful 
therapeutic tool, methylation-mediated repression of specifically targeted genes 
could yield an alternative to transgenic knockouts for studying loss-of-function 
phenotypes. Silencing genes through DNA methylation would be particularly 
valuable in the case of essential genes where tissue-specific knockouts of 
function are needed. Finally, the ability to target m5C specifically in vivo is likely 
to prove valuable in basic investigations of the biological roles and mechanistic 
consequences of DNA methylation. 
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